WO2009144615A1 - Moisture control within a multi-electrode patch for monitoring and electrical stimulation of wound healing - Google Patents
Moisture control within a multi-electrode patch for monitoring and electrical stimulation of wound healing Download PDFInfo
- Publication number
- WO2009144615A1 WO2009144615A1 PCT/IB2009/052063 IB2009052063W WO2009144615A1 WO 2009144615 A1 WO2009144615 A1 WO 2009144615A1 IB 2009052063 W IB2009052063 W IB 2009052063W WO 2009144615 A1 WO2009144615 A1 WO 2009144615A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- electrodes
- matrix
- skin
- load
- Prior art date
Links
- 238000012544 monitoring process Methods 0.000 title claims description 15
- 230000000638 stimulation Effects 0.000 title claims description 15
- 230000029663 wound healing Effects 0.000 title description 31
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 206
- 239000011159 matrix material Substances 0.000 claims abstract description 66
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 34
- 206010072170 Skin wound Diseases 0.000 claims abstract description 29
- 238000011282 treatment Methods 0.000 claims abstract description 21
- 239000000758 substrate Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 75
- 239000000463 material Substances 0.000 claims description 55
- 239000000017 hydrogel Substances 0.000 claims description 28
- 239000002674 ointment Substances 0.000 claims description 24
- 230000004044 response Effects 0.000 claims description 10
- 230000007423 decrease Effects 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 177
- 230000035876 healing Effects 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 239000003814 drug Substances 0.000 description 19
- 238000005259 measurement Methods 0.000 description 19
- 229940079593 drug Drugs 0.000 description 18
- 230000001276 controlling effect Effects 0.000 description 17
- 230000005684 electric field Effects 0.000 description 17
- 239000002245 particle Substances 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 239000000645 desinfectant Substances 0.000 description 10
- 238000012377 drug delivery Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000003102 growth factor Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- -1 e.g. Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- 239000003990 capacitor Substances 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 230000003578 releasing effect Effects 0.000 description 5
- 229960003600 silver sulfadiazine Drugs 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 4
- 101800003838 Epidermal growth factor Proteins 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000000337 buffer salt Substances 0.000 description 4
- 230000012292 cell migration Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000003246 corticosteroid Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940116977 epidermal growth factor Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000002838 chemorepellent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004720 dielectrophoresis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000002847 impedance measurement Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000036573 scar formation Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- FIOCEWASVZHBTK-UHFFFAOYSA-N 2-[2-(2-oxo-2-phenylacetyl)oxyethoxy]ethyl 2-oxo-2-phenylacetate Chemical compound C=1C=CC=CC=1C(=O)C(=O)OCCOCCOC(=O)C(=O)C1=CC=CC=C1 FIOCEWASVZHBTK-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 108010066486 EGF Family of Proteins Proteins 0.000 description 1
- 102000018386 EGF Family of Proteins Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 239000002519 antifouling agent Substances 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000005109 electrotaxis Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940099261 silvadene Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- BWYYYTVSBPRQCN-UHFFFAOYSA-M sodium;ethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=C BWYYYTVSBPRQCN-UHFFFAOYSA-M 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003956 transport vesicle Anatomy 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0226—Adhesive bandages or dressings with fluid retention members characterised by the support layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00429—Plasters use for conducting tests
- A61F2013/00442—Plasters use for conducting tests using electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
- A61F2013/00523—Plasters use for treating burn with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00536—Plasters use for draining or irrigating wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0094—Plasters containing means for sensing physical parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0094—Plasters containing means for sensing physical parameters
- A61F2013/00944—Plasters containing means for sensing physical parameters humidity; moisture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
Definitions
- the present invention relates to moisture control with a multi-electrode patch for electrical stimulation and monitoring of wound healing and to a method for controlling moisture in the electrical treatment of a skin wound.
- Electrodes of wound healing has been suggested as an adjunctive treatment for wound healing for many years. It involves the placement of electrodes in direct contact with, or in close proximity to, a skin wound thereby creating an electrical current or voltage that passes through either the wound or peripheral tissue.
- Huttenlocher (NEJM 356(3), 2007) clearly shows the movement of a cell under the influence of an electrical field. The movement is directed towards the cathode.
- Wound healing is a complex process with several distinguishable stadia (cf: Gurtner et al, Wound repair and regeneration, Nature Insight 453, 314-321 (2008)). In general it can be categorized into the following four healing phase conditions:
- the necrotic condition refers to the wound healing phase condition where catabolic processes have been resulting in dead tissue.
- the fibrinous slough or infection condition refers to the circumstance where the wound is in the inflammatory phase, where dead cellular debris fills the base of the wound with an off-white to yellow layer,
- the granulation condition refers to the healing phase when the wound has reached the proliferative stage of healing and when the wound cavity is slowly filled with the "repair-material" of the body which consists of f ⁇ bro -vascular tissue and is called granulation.
- the epithelialisation condition describes the wound healing phase wherein the keratinocytes (epidermal cells) are dividing and gradually crossing the wound surface from the margins towards the opposite side. Once the cells make contact with each other the cells stop dividing (contact inhibition).
- Dressings that maintain a moist wound may be, for instance, based on hydrocolloids that are applied directly over the wound. This dressing is impermeable to oxygen, moisture and bacteria. Alternatively, absorptive dressings can be utilized. They are not pre -moisturized but rather absorb moisture from exudates in the wound to keep a moist environment. Normally, they can absorb up to 20 times their weight and may be especially suited for wounds with large amounts of exudates. Calcium alginate dressings such as
- Sorbsan® or Kalostat® are two types of soft, fibrous absorptive dressings that are derived from seaweed.
- U.S. Patent 6,915,950 discloses methods that record the wound conditions in relation to moisture conditions. In order to avoid infections, a gradual release of disinfectants is sometimes helpful to support wound healing. Suitable disinfectants are saline or silver sulfadiazine (e.g. Silvadene®).
- saline or silver sulfadiazine e.g. Silvadene®
- administration with systemic antibiotics is not warranted unless the patient is demonstrating signs of a systemic infection. In that case the goal of antibiotic treatment is not wound sterilization, but rather control of bacterial growth. Often ointments containing a number of topical agents including sugar, antacids, vitamins A and D are used.
- Controlling moist conditions is obviously important for wound healing. However, controlling the hydration conditions over a longer period is a problem. This is normally done by regular renewal of the moisturizing ointment.
- the ointment is filled with particles which are loaded with water, and eventually other additives, which may be released in time.
- the particles may be embedded in viscous liquids such as peptide mixtures, glycerine, etc.
- the emission of water from the particles is high at the onset, but decreases in time.
- semi-solids, such as gels are used to cover the wound. See U.S. Patent 5,905,092 which describes a composition with water loads of more than 60%.
- the water content offered to the wound decreases with time and, in order to create acceptable average conditions, is too high at the onset and too low at the end, before renewal of the composition.
- Another limitation often not addressed is that, under certain conditions, the wound might be exuding moisture by itself, thereby increasing the moisture conditions to an excessive level. Also, over time, as the wound healing process approaches fmalization, the ideal moisture concentration will change, though at the end of the healing process the maintenance of moisture control is less important.
- a means e.g., in the form of a special plaster, gel, ointment or other composition, that allows for controlling the moisture conditions over time by measuring the moisture concentration associated with a wound and subsequently releases or uptakes moisture to maintain optimal moisture levels.
- it would be supportive for wound healing if the same means can be used to emit disinfectants/antibiotics or wound-healing promoters, such as steroids.
- the moisture content could be locally regulated, e.g., providing a water load or moisture content at the periphery of the wound that is different from the center of the wound.
- the present invention provides a device for electrical treatment of a skin wound comprising a flexible substrate adapted for attaching to the skin wound and the surrounding skin, a matrix of electrodes, means for determining the presence of the wound and/or its perimeter and/or and means for applying a voltage between the wound and its surrounding.
- the means for determining the presence of the skin wound may comprise one or more sensors for detecting the real-time state of the skin wound.
- a “skin wound” according to the present invention may be any injury, burning or lesion of the skin including irritations and inflammations.
- ES is preferably applicable in case of chronic wounds such as stage III or stage IV pressure ulcers, arterial diabetic ulcers and venous static ulcers.
- the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the electrodes at and/or close to the wound are charged opposite with respect to the electrodes surrounding the wound or its perimeter at a predetermined distance.
- the electrodes around and on top of the wound may be made negative and other electrodes further away may be made positive, or vice versa.
- a counter electrode may be incorporated in the patch.
- the electrodes further away are chosen at a fixed distance from the perimeter of the wound, wherein the number of positive electrodes equals the number of negative electrodes.
- a voltage between the wound and its surrounding may as well be achieved by different means.
- the electrodes at and/or close to the wound and the electrodes surrounding the wound or its perimeter at a certain distance have to be set on different electric potentials.
- the electrodes around and on top of the wound may be grounded and other electrodes further away may be set on a positive potential.
- More complex patterns of charge or potential may also be applied. It is, e.g., preferred that the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the electric potential gradually increases or decreases from the electrodes at and/or close to the wound towards the electrodes surrounding the wound or its perimeter at a predetermined distance. This may be achieved by providing several rings of electrodes which are set on different electric potential. In another preferred embodiment, a gradient in voltage from the electrodes in the most outer regions of the matrix towards the electrodes situated near or on top of the wound is applied. Of course, the gradient may alternatively be directed from the center towards the periphery. It is preferred that the device further comprises means for measuring the electric current caused by the applied voltage.
- the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the measured current does not exceed a predetermined threshold. It is thus prevented that skin under the electrodes is irritated or even burned due to excessively high currents, which can cause Joule heating and consequently burning of skin.
- the presence/location of the wound and/or its perimeter may be determined by measuring the impedance between each electrode and its neighboring electrodes.
- the voltage to be applied between at least some of the electrodes is then determined or calculated by an on-board or external control module in response to the location of the wound and/or its perimeter.
- the device is adapted for repeatedly determining the location and/or perimeter of the wound and readjusting the applied voltage pattern in predetermined time intervals. For instance, some wounds tend to heal from the perimeter towards the center. Accordingly, the largest voltage should be applied at the perimeter of such wounds. After some progress in healing the wound may be smaller and its perimeter may have migrated. Thus, the applied voltage pattern has to be re-adjusted in predetermined long-time intervals.
- the means for applying a voltage may also be adapted to apply a varying voltage over short time intervals.
- short DC current pulses may be applied, which travel towards the wound.
- AC electric fields may be used utilizing the effect of dielectrophoresis to stimulate the movement of cells towards the wound.
- the voltage is between 1 V and 10 V and the frequency between 10 kHz and 100 kHz.
- the matrix of electrodes may be coated with a therapeutical agent.
- the therapeutical agent may comprise one or a combination of the following substances: growth factors, e.g. epidermal growth factors, polymer or lipid micells and/or vesicles suitable for drug delivery, corticosteroid-based drugs, anti-inflammatory proteins. If the electrodes, e.g., are coated with an epidermal growth factor and a gradient in voltage towards the wound is applied, the growth factor is "injected" into the wound. This should promote cell migration and accelerate healing.
- the composition of vesicles in particular of transport vesicles, can be tailored to encase therapeutic agents such as drugs or growth factors while the surface of the vesicle can be tailored to a specific charge.
- a "drug delivery" vesicle can be designed such that it responds to the electrical fields in a distinct manner from the natural environment (i.e. say inflammatory inducing cells). This can ensure the movement and localization of only said drug delivery vesicle, whilst leaving the surrounding tissue unperturbed.
- the electric patch can also be used to create a locally defined gradient of chemo-repellant either via a charged drug, or anti-inflammatory protein, or via a complex drug delivery vehicle.
- the device according to the present invention comprises large area electronics on a polyimide release layer.
- the invention is not limited thereto and any type of flexible substrate suitable to be attached to skin may be used in combination with any matrix of electrodes.
- temperature sensors can be integrated into the electrically active patch so that the temperature of the wound can be measured. This is advantageous for detecting the presence of an infection as the skin temperature typically increases from 32°C to 37°C when a wound becomes infected. These sensors can also be formed in an array to allow a temperature map of the wound to be created. Most preferably the electrode geometry and material are chosen so that the electrode pad functions as both a resistive temperature sensor, a means for measuring impedance, and also for applying the voltage or current for healing.
- heaters can be integrated into the active patch so that the temperature profile over the wound can be controlled to influence the healing process.
- the moisture of the wound can also be measured via the electrically active patch and this measurement used to monitor the healing process.
- the active patch can use high frequency radiation, such as THz radiation, generated locally on the patch to monitor the healing process.
- high frequency radiation such as THz radiation
- the present invention further provides a method for electrical treatment of a skin wound comprising the following steps: placing a matrix of electrodes attached to a flexible substrate on top of the skin wound; determining the presence of the wound and/or its perimeter; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance.
- the electric potential gradually increases or decreases from the electrodes at and/or close to the wound towards the electrodes surrounding the wound or its perimeter at a predetermined distance.
- the steps of determining the location and/or perimeter of the wound and applying a potential to the electrodes are preferably repeated in predetermined time intervals in order to adjust the resulting applied voltage/current to the actual status of the wound and its progress in healing.
- the step of determining the location and/or perimeter of the wound may be performed by measuring the impedance between each electrode of the matrix and its neighboring electrodes. Since wounded skin has a different conductivity compared to healthy skin, the local impedance allows for determining the location of the wound.
- the inventive method further comprises the step of measuring the current between the electrodes.
- the potential applied to the electrodes is controlled in such a way that the measured current does not exceed a predetermined threshold in order to avoid irritation or burning of the skin due to excessively high currents.
- the electric potential applied to the electrodes is varied over time.
- an AC field is applied between the electrodes, wherein the voltage of the AC field is between 1 V and 10 V and the frequency is between 10 kHz and 100 kHz.
- the matrix of electrodes is preferably coated with a therapeutical agent, which may comprise one or a combination of the following substances: a growth factor, e.g., an epidermal growth factor, polymer or lipid micells and/or vesicles suitable for drug delivery, corticosteroid-based drugs, anti-inflammatory proteins.
- a growth factor e.g., an epidermal growth factor, polymer or lipid micells and/or vesicles suitable for drug delivery
- corticosteroid-based drugs e.g., an anti-inflammatory proteins.
- the device and method according to the present invention provide several advantages over the prior art. Since the current applied during the therapy or stimulation is measured and controlled, skin irritation or even burning can be avoided. A considerable lateral movement of cells may be achieved due to the applied currents. The wound and its process of healing can be monitored during the therapy or stimulation. Accordingly, at every stage of healing the patch of electrodes may be controlled in response to the actual status of the wound. Due to the matrix technology any type of field or waveform can be applied allowing for an enormous versatility of the inventive device.
- the device for treatment of a skin wound includes a flexible substrate adapted for attaching to the skin wound and the surrounding skin, a matrix of electrodes, a means for determining the presence of the wound and/or its perimeter and/or means for electrically monitoring the water content and controlling a liquid load between the matrix and the wound, and means for applying a voltage between the wound and the surrounding skin.
- the matrix of electrodes may include a single electrode, and/or multiple electrodes. The single electrode arrangement presents a simple mechanical arrangement, but may require a more complex electronic driving scheme.
- the matrix of electrodes may be selected from the group consisting of interdigital electrodes, patterned electrodes and transistor- or diode-driven patterned electrodes.
- the means for controlling a liquid load between the matrix and the wound includes a plurality of load-uptaking material, such as a plurality of miniaturized liquid-containing elements.
- a load-uptaking material such as a plurality of miniaturized liquid-containing elements.
- This may include a hydrogel material which is adapted to absorb a liquid load, and is adapted to release the liquid load in response to an electrical stimulation from the matrix of electrodes.
- the plurality of load-uptaking material is arranged within an ointment.
- the liquid load may be selected from the group consisting of water, buffer salts, disinfectant, saline, silver sulfadiazine, healing steroids, or combinations thereof.
- a plurality of different liquid loads may be in the plurality of separate load-uptaking materials. This arrangement provides for each of the different liquid loads to be released selectively, depending on the wound conditions.
- a method for electrical treatment of a skin wound comprising the steps of placing a matrix of electrodes attached to a flexible substrate on top of the skin wound and the surrounding skin; determining the presence of the wound and/or its perimeter and/or electrically monitoring the water content and controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance.
- the selective application of electric potential to selected areas on or about the wound promotes faster and more effective healing.
- the steps of determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance are repeated in predetermined time intervals.
- the same pattern is not necessarily repeated endlessly, but a pattern of electric potential may be applied repeatedly in response to the condition of the wound and the determination of the water content in or around the wound.
- the step of electrically monitoring the water content between the matrix of electrodes and the wound includes measuring an electrical property between each electrode of the matrix and its neighboring electrodes.
- the electrical property may be selected from the group consisting of impedance, conductance and capacitance.
- the steps of controlling a liquid load between the matrix of electrodes and the wound, and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance results in the release of the liquid load from a plurality of load-uptaking materials between the matrix of electrodes and the wound. Different load-uptaking materials may be used, wherein each of the different material requires a distinct electrical signal or condition to release the liquid load contained therein.
- Fig. 1 shows a flexible array of electrodes in a device for treatment of a skin wound, in accordance with an embodiment of the invention
- FIG. 2 schematically illustrates an arrangement for operation of electrodes in a device for treatment of a skin wound, in accordance with an embodiment of the invention
- Fig. 3 illustrates an applied voltage gradient directed towards a wound, in accordance with an embodiment of the invention
- Fig. 4 shows a traveling wave driving towards a wound, in accordance with an embodiment of the invention
- Fig. 5 shows a low field driving towards a wound, in accordance with an embodiment of the invention
- Fig. 6 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material applied to a wound, in accordance with an embodiment of the invention
- Fig. 7 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material or a polymer or solid gel with load-uptaking and releasing properties between the electrodes applied to a wound, in accordance with an embodiment of the invention
- Fig. 8 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material applied to a wound, including dedicated interdigitated electrodes for determining local water content of the wound, in accordance with an embodiment of the invention
- Fig. 9 shows a schematic view of a device for measuring conductivity and/or thermal heat capacity for determining water content associated with a wound, in accordance with an embodiment of the invention.
- Fig. 1 shows a flexible array 1 of electrodes 2 as now for instance also used in displays.
- Such flexible arrays, e.g., patch or matrix, 1 can be made from large area electronics technology on a polyimide release layer, which is often referred to as EPLAR. Similar technologies may be applied for the device according to the present invention.
- Fig. 2 schematically illustrates how a device according to a preferred embodiment of the present invention is used.
- a patch or matrix 1 of electrodes is placed on top of the wound 3 (see Fig. 2(a)).
- the electrodes 2 are then scanned and the impedance between each electrode and its neighbouring electrodes is measured. Since wounded skin will have a different conductivity compared to healthy skin, the presence and location of a wound 3 and therefore its perimeter can be determined.
- the electrodes 2b around and on top of the wound may be charged with an electrical potential, e.g., negatively charged.
- Other electrodes 2a, further away from the wound may be made positive, or vice versa.
- the most simple arrangement is to charge the electrodes 2a at a fixed distance from the perimeter of the wound 3 positively and to charge the same number of electrodes negatively as were made positive.
- the current or voltage waveform is applied for a fixed period of time.
- the resulting current from the positive electrodes 2a to the negative electrodes 2b is indicated with arrows in Fig. 2(c).
- the amount of current that can be supplied via each segmented electrode is limited to avoid burning. If too large a current is to be supplied between two electrodes 2a, 2b, then the current is redistributed to neighbouring electrodes.
- the step of scanning the electrodes is repeated and the size and conductivity of the wound is compared to the previous measurement(s). The current or waveform can then be adjusted accordingly to enhance healing.
- the monitoring is not done via measuring the drawn current, but by measuring the impedance of the skin under each electrode. This is done at either a pre-determined frequency or by performing a frequency sweep. From the impedance data the state of the wound, e.g., both size and stage of healing, can be extracted and compared to previous measurements.
- Fig. 2 it may be preferred not to create only one ring of positive electrodes but to create a gradient in voltage from the electrodes 2a in the most outer regions of the patch towards the electrodes 2b situated near or on top of the wound, as illustrated in Fig. 3.
- several rings 4a to 4f may be set on different potentials with the potential gradually increasing or decreasing from the center of the wound to the periphery of the patch or matrix 1.
- such an array patch 1 allows for the generation of time- variable in-plane electrical fields. This creates many new methods for driving the electrodes which were not possible in the case of mono-electrode patches. For example, it has been shown that applying a short DC current pulse is effective for healing. With such an array patch it is possible to create a pulse on an electrode and to allow this pulse to travel towards the wound. Alternatively it is also possible to apply AC electric fields instead of DC fields. The physical effect of dielectrophoresis could then be used to stimulate the movement of cells towards the wound or to spread the cells to provide an array of nucleation sites from which the wound healing initiates thus controlling, among others, scar formation. The voltage applied is typically a few volts and in the frequency range of 10-100 kHz.
- a so called travelling wave driving waveform can be seen in Fig. 4 where different phases of sine wave voltage are applied to electrodes which surround the wound.
- This type of driving is, however, not the most effective if the cells are in a saline environment, as may be the case on a wound.
- a low field driving scheme wherein an area of low electrical field is created and moved in the direction of the wound. This is illustrated schematically in Figs. 5(a) to 5(d).
- the migration of cells to the wound has been a purely electrically driven process. It is, however, also possible to envisage a process which is indirectly driven by an electrical field, but is of chemical nature.
- Cell migration in the body is usually driven chemically and is referred to as chemotaxis.
- the cells at inflammation sites excrete various proteins which include cellular growth and differentiation factors.
- Specific cell types e.g., immune cells, or stem cells, respond to these chemically- excreted signals and migrate towards the source. If a gradient in growth factor could be created towards the wound then this would also promote cell migration.
- Charged molecules, such as drugs or proteins, can be given to a patient transdermally via a process called iontophoresis.
- the electrodes are coated with a growth factor such as EGF (epidermal growth factor) and a gradient in voltage towards the wound is applied (such as in Fig. 3). This will "inject” the growth factor into the skin with a gradient which is determined by the voltages applied to the segmented electrodes.
- the growth factor gradient is therefore in the direction of the wound and should therefore promote cell migration and accelerated healing.
- vesicles can be tailored to encase drugs (or growth factors) while the surface of the vesicle can be tailored to a specific charge.
- drug delivery vesicle can be designed such that the vesicle responds to the electrical fields in a manner distinct from the response of the natural environment, i.e., inflammatory inducing cells. This can ensure the movement and localization of only said drug delivery vehicle, whilst leaving the surrounding tissue unperturbed.
- the stimulated migration of cells towards damaged tissue can have great benefits with respect to healing and tissue repair.
- persisting inflammations i.e., non-open wounds, with swelling, necrosis and inflammation, are often treated with inflammation suppression drugs.
- Such drugs act to suppress the localization and/or activation of immuno -cells at the sites of inflammation. Nonetheless, these drugs are not recommended for long term use, due to side effects and cellular adaptations.
- Similar to the manner in which cells can be stimulated electrically to migrate towards a source one can also "repel" cells electrically and chemically. Similar to the embodiment described above, the electrically active patch or matrix 1 can be applied over an inflamed area and the electric fields tuned to repulse inflammatory cells.
- the electrically active patch 1 can also be used to create a locally defined gradient of chemo-repellant either via a charged drug, or antiinflammatory protein, or via a complex drug delivery vehicle.
- temperature sensors can be integrated into the electrically active patch 1 so that the temperature of the wound 3 can be measured. This is advantageous for detecting the presence of an infection as the skin temperature typically increases from 32°C to 37°C when a wound 3 becomes infected. These sensors can also be formed in an array to allow a temperature map of the wound to be created. Most preferably, the electrode geometry and material are chosen so that the electrode pad functions as both a resistive temperature sensor, a means for measuring impedance, and also for applying the voltage or current for healing.
- heaters can be integrated into the active patch 1 so that the temperature profile over the wound 3 can be controlled to influence the healing process.
- the active patch can use high frequency radiation, such as THz radiation, generated locally on the patch to monitor the healing process.
- high frequency radiation such as THz radiation
- the moisture of the wound 3 can also be measured via the electrically active patch 1 and this measurement may be used to monitor and manipulate the healing process.
- a device for the treatment of a skin wound 3 includes a flexible substrate 1 adapted for attaching to the skin wound 3 and the surrounding skin, a matrix 1 of electrodes 2, means for determining the presence of the wound 3 and/or its perimeter and/or means for electrically monitoring the water content and controlling a liquid load between the matrix 1 and the wound 3, and means for applying a voltage between the wound 3 and the surrounding skin.
- the matrix 1 of electrodes 2 may include a single electrode, and/or multiple electrodes. The single electrode arrangement presents a simple mechanical arrangement, but may require a more complex electronic driving scheme.
- the device electronically monitors the water concentration in and around the wound 3 and electrically stimulates the release or absorption of water, disinfectants and/or treatment drugs in a measure -response-feed-back cycle.
- the electrode array is a single- electrode or multiple-electrode arrangement which may consist of interdigital electrodes, patterned electrodes, transistor or diode driven patterned electrodes.
- Interdigital electrodes are electrodes of different types or arrangements which are woven or arranged very closely together so as to be effectively inseparable and to provide the possibility for a number of different types of simultaneous measurements and the application of different electrical potentials simultaneously, or nearly so, in a single matrix 1 array.
- interdigitated electrodes or electrode arrays are used in one embodiment.
- the electrode array 1 functions to provide local detection and quantification of water in and around the wound 3.
- the electrode array 1 also functions to release water or other substances, e.g., a liquid load, from miniaturized water containers accommodated in an ointment between the electrode array 1 and the wound 3.
- the means for controlling a liquid load between the matrix 1 and the wound includes a plurality of load-uptaking material, such as a plurality of miniaturized liquid-containing elements.
- a plurality of load-uptaking material such as a plurality of miniaturized liquid-containing elements.
- This may include a hydrogel material which is adapted to absorb a liquid load, and is adapted to release the liquid load in response to an electrical stimulation from the matrix 1 of electrodes 2.
- a plurality of load-uptaking material is meant to include a number of identical or dissimilar discrete load-uptaking elements within an ointment, or a generally solid gel or polymer, which may be homogeneous in composition, having load-uptaking and releasing properties and generally corresponding to the number of identical or dissimilar discrete load-uptaking elements.
- the plurality of load-uptaking material is arranged within an ointment.
- the liquid load may be selected from the group consisting of water, buffer salts, disinfectant, saline, silver sulfadiazine, healing steroids, or combinations thereof.
- a plurality of different liquid loads may be in the plurality of separate load-uptaking materials. This arrangement provides for each of the different liquid loads to be released selectively, depending on the wound conditions.
- hydrogel materials there are several suitable miniaturized water-containing materials, e.g., hydrogel materials, that can be loaded with water by swelling and which may be directed to release their water load by electrically-stimulated de-swelling, e.g., contraction, shrinking.
- the liquid load may be as simple as water, or it may be water that contains buffer salts to make it more physiologically normalized. However, the liquid load may also contain disinfectants or antibiotics such as saline, silver sulfadiazine or steroids that promote healing, such as estrogens. Combinations of these materials may also be used.
- Direct information regarding the water concentration and water distribution over, on or around the surface of the wound 3 may be obtained from high frequency impedance/conductance or capacitive measurements through the electrodes at the various locations of the device-wound interface. This measurement is not trivial given the complex composition of the various components and the presence of ion-rich water-containing materials. Of direct interest is the amount of water concentrated at or near the interface with the wound 3. Some detailed solutions will be provided in the next section. Alternatively, single-electrode methods may be used to make the design of the water-releasing element more simple, but may be more complicated in an electronic sense.
- a method for electrical treatment of a skin wound comprising the steps of placing a matrix 1 of electrodes 2 attached to a flexible substrate on top of the skin wound 3 and the surrounding skin; determining the presence of the wound 3 and/or its perimeter and/or electrically monitoring the water content and controlling a liquid load between the matrix 1 of electrodes 2 and the wound 3; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance.
- the selective application of electric potential to selected areas on or about the wound promotes faster and more effective healing.
- the steps of determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance are repeated in predetermined time intervals.
- the same pattern is not necessarily repeated endlessly, but a pattern of electric potential may be applied repeatedly in response to the condition of the wound and the determination of the water content in or around the wound.
- the step of electrically monitoring the water content between the matrix of electrodes and the wound includes measuring an electrical property between each electrode of the matrix and its neighboring electrodes.
- the electrical property may be selected from the group consisting of impedance, conductance and capacitance.
- the steps of controlling a liquid load between the matrix of electrodes and the wound, and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance results in the release of the liquid load from a plurality of load-uptaking materials between the matrix of electrodes and the wound.
- Different load-uptaking materials may be used, wherein each of the different material requires a distinct electrical signal or condition to release the liquid load contained therein.
- the load-uptaking material may be used, wherein each of the different material requires a distinct electrical signal or condition to release the liquid load contained therein.
- the load-uptaking material 6 may be a swelling polymer made by lithographic means or by replication processes, e.g., as described in [M.H.M. Oudshoorn, R. Penterman, R. Rissmann, J.A. Bouwstra, D.J. Broer, W.E. Hennink, Preparation and Characterization of Structured Hydrogel Microparticles Based on Cross- Linked Hyperbranched Poly 'glycerol, Langmuir 23 (23), 11819-11825 (2007)], although for this specific application other materials of a different chemical nature may be selected. Suitable materials may include copolymers made from acrylamide and acrylic acid crosslinked by small amounts of bisacrylamide.
- These materials may be made by photopolymerization of the monomer mixtures and loaded with water and other components. Upon the application of an electrical field these copolymers are know to contract (de-swell) at the anode side thus releasing their load, as illustrated in Fig. 6 and in [Tanaka, T., Nishio, L, Sun, S. -T., and Ueno -Nishio, S., Collapse of gels in an electric field, Science 218, 467-469 (1982)]. By reversing the cathode and anode, the opposite part can be contracted to release its liquid load.
- the loaded particles may be embedded in a viscous base material, e.g., glycerol, polyethylene glycol oligomer, mixture of proteins, etc., to make an ointment as schematically shown in Fig. 6.
- a viscous base material e.g., glycerol, polyethylene glycol oligomer, mixture of proteins, etc.
- the viscous base material is electrically (ionic) conductive and transparent for water diffusion to some extent. Flaked materials as liquid-loaded materials are of special interest because they simplify the manufacturing of ointments.
- different liquid-bearing particles 6 may be filled with different liquid loads or fluids, e.g., first particles 6 loaded with water or physiological salt solution and a second particles 6 loaded with antibiotics/disinfectants.
- These different liquid- bearing particles 6 may be triggered by different stimuli, e.g., different voltages.
- This arrangement provides the possibility for different fluids or liquid load to be release at different times, in a controllable manner.
- One fluid e.g., water
- the second fluid e.g., disinfectant
- flake material for liquid-loading may be desirable because: 1. Ointments may be easily made from such materials, and
- a blend of different flakes may be used, i.e., with different liquid-loading, e.g., water and water plus drug, or having different electrical or thermal response.
- the ointment 5 containing the loaded hydrogel material 6 is applied as a coating in between electrodes 2 of the electro- stimulating device, as is illustrated in Fig. 7.
- the hydrogel ointment 5, or a gel or polymer having liquid- uptaking and releasing properties, may be embedded in small notches in the matrix 1 to generate more volume.
- the hydrogel material 6 is loaded with the liquid-loading/healing-promoting ingredients.
- this liquid load can be as simple as water, or it can be water-containing buffer salts to make it more physiologically normal. It may also contain disinfectants such as saline, silver sulfadiazine or healing- promoting steroids, such as estrogens. Combinations of these materials may be used as well.
- the device may include a stack of multiple layers which may be applied onto the wound 3.
- a first layer of the stack which may be in contact with the wound 3, may comprise a plurality of hydrogel 6 aggregates or hydrogel flakes for triggered release of the substances as described above.
- the second layer could be a hydrogel ointment 5, 6 layer as well but with additional ingredients, e.g., immobilized antifouling agents.
- each of the stored agents/liquid load materials 6 may be released on command, i.e., each different type of load-uptaking material 6 may be release at a different moment in time.
- each different type of load-uptaking material 6 may be release at a different moment in time.
- different types of hydrogels and load-uptaking materials may be applied, each of which may be separately triggered to start and/or stop release of said agent/load uptaking materials 6.
- the hydrogel particles 6 were made by copolymerizing a mixture of: 80 wt-% acrylic acid, 16 wt- % sodium vinyl sulfonate; 2 wt-% N ',N '-methylene bisacrylamide; and 2wt-% 2-Hydroxy-2- methyl- 1 -phenyl- 1-propanone Irgacure 754 - from Ciba Specialty Chemicals.
- the mixture was applied in a nickel mould that was provided with a release agent.
- the mould included a number of small containers of approximately 50x50x5 ⁇ m and the mixture was cured by UV light. After fully cured, the polymer flakes were released from the mould by moderate bending. The flakes were saturated with an aqueous NaCl solution by immersion for 2 days at 25 0 C. Subsequently, a mixture was made of 70 wt-% of the saturated particles with 30 wt-% of mixture containing 3 parts glycerol and 1 part chitosan. The ointment 5 that is formed is applied between the wound 3 and the device containing the multi electrode array 1, as illustrated in Fig. 6.
- the hydrogel 6 flakes start to release water at a DC voltage of 3 Volts. It is desired to uncouple the electro -stimulated release of water or other ingredients from the electrical field or current that is utilized for electro-stimulated wound healing.
- the solution is to use an alternating current for the electrical wound healing stimulation and a direct current for water/drugs release from the hydrogel materials 6.
- the hydrogel material 6 tends to start uptaking water again. This is a slow and diffusion-controlled process.
- the DC voltage should be repeated intermittently in coordination with the AC fields used to stimulate wound healing.
- An appropriate sequence of DC and AC field-addressing is therefore part of the invention.
- a mixture is made containing: 1 gram hyaluronic acid; 5 ml 1 N NaOH solution; and 0.55 ml of 0.8 g/1 ethylene glycol diglycidyl ether in ethanol.
- the mixture is poured onto an electrode array 1 where the solution fills the gap between the electrodes 2.
- the mixture is allowed to react at 60 0 C where the hyaluronic acid crosslinks.
- the formed gel is removed from non-reacted components by placing it in an excess of distilled water for 3 days and dried. Then the gel is loaded by a 1 g/1 solution of estrogen in water over 3 days contact.
- the electrode structure havine the loaded hydrogel between the electrodes 2, as shown in Fig. 7, is manipulated by applying an AC field for electrical stimulation of wound healing and a DC field for drugs and water release in an alternate basis.
- Fig. 8 This arrangement provides an example of dissimilar interdigitated electrodes incorporated into a single matrix 1. Numerous variations are possible, whereby numerous measurements may be taken to determine various conditions in or around the wound simultaneously, while numerous dissimilar electric potentials may be applied in different areas of the matrix 1, as a result of the measurements.
- this arrangement may include the risk of a delay between the measured water concentration and the actual water concentration, through the miniaturization of the water measurement electrodes 7 the delay time can be reduced.
- an interdigital array of electrodes may also be used. Examples thereof, e.g., for measuring water contents of oil or paper pulps, are given in literature. Cf. Sundara-Rajan et al, IEEE Sensor Journal (2004).
- An insulating dielectric 8 may be included between the water measurement electrodes 7.
- the insulating dielectric 8 may be a polymer that is applied by lithographic means.
- the top of the water detection electrodes 7, together with the insulating dielectric 8 may be covered with a thin membrane, e.g., SiO 2 , in accordance with the principles of fringe field detection [Cf. Mamishev et al, Inter digital sensors and transducers, Proc. IEEE 92, 808 (2004)].
- a single electrode capacitance probe is described by Sch ⁇ ller et al,
- the operating frequency ⁇ of the oscillator 9 depends on the inductance of the coil of the oscillator circuit L and the capacitance C m of the medium located near the electrode
- the capacitance change of the medium outside the electrode is related to the operating frequency change of the oscillator as follows:
- the range of C m is highly dependent on the size (area) and shape of the electrode and of the shape (thickness) of the ceramic 11.
- a polymer film may be used, the polymer film being more compliant with respect to the shape of the body and the wound 3.
- the conductivity of the ointment 5 with the hydrogel material 6 will depend on the water concentration within.
- the conductive particles may be any number of small conductive materials, e.g., silver or gold nanoparticles, iron/ironoxide nanoparticles or carbonanotubes.
- the conductive particles are covalently coupled to the hygroscopic polymer matrix.
- a coating may be applied locally.
- Hygroscopic polymers may be applied between some of the electrodes 2 to provide a number of sensing compartments next to delivering compartments. Controlling and applying local coatings would allow the device to follow the wound perimeter and control wound healing while the wound is getting smaller. This may lead to better and faster wound healing as well as to decreased scar formation. Methods based on thermal heat capacity.
- the electrical release substrate e.g., liquid- loaded hydrogels
- the electrical release substrate e.g., liquid- loaded hydrogels
- the electrical release substrate could be provided with a miniature Joule heater, or an array of such heaters, and a resistive wire(s) for determining the actual temperature T.
- the skin temperature T could be measured, and a sharp pulse in temperature with respect to skin temperature T may be created by applying current to the heater.
- the heat capacity, and therefore the volume of the water in the gel may be closely estimated. It is necessary that the rise in T is rapid to avoid the body mass acting as a thermal sink.
- the temperature sensors could also be used for determining if an infection is present. Normal skin temperature is 32°C and this can increase to 37°C upon infection. Provided that no infection is detected then the moisture could be maximised.
- the invention is concentrating on accelerated wound healing.
- other applications are envisioned, such as beauty treatments with other stimulating agents and/or fragrances.
- electrical stimulation has been reported to be helpful in accelerating the healing process and nerve regeneration after injury. Electrical currents/charges could change cell membrane permeability, stimulate cell activities such as DNA synthesis and cell proliferation. Local electrical currents may improve arterial blood flow and reduce tissue edema and microvascular permeability. This improvement in circulation may increase tissue oxygenation.
- Electrical stimulation for clinical use can be delivered via various mechanisms, including direct injection of an electrical charge using metal electrodes in resistive contact with tissues, induction of eddy currents in tissues by rapidly changing magnetic fields applied externally, and creation of electrostatic field in tissues by high- voltage external capacitive plates.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides a device for electrical treatment of a skin wound comprising a flexible substrate adapted for attaching to the skin wound and the surrounding skin, a matrix of electrodes, means for determining the presence of the wound and/or its perimeter and/or means for controlling a liquid load between the matrix (1) and the wound, and means for applying a voltage between the wound and the surrounding skin. The present invention further provides a method for electrical treatment of a skin wound comprising the following steps: placing a matrix of electrodes attached to a flexible substrate on top of the skin wound and the surrounding skin; determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a potential differential between particular electrodes, wherein the absorption or release of the liquid load is controlling to maintain optimum moisture content at and/or close to the wound.
Description
Moisture control within a multi-electrode patch for monitoring and electrical stimulation of wound healing
FIELD OF THE INVENTION
The present invention relates to moisture control with a multi-electrode patch for electrical stimulation and monitoring of wound healing and to a method for controlling moisture in the electrical treatment of a skin wound.
BACKGROUND OF THE INVENTION
Electrical stimulation (ES) of wound healing has been suggested as an adjunctive treatment for wound healing for many years. It involves the placement of electrodes in direct contact with, or in close proximity to, a skin wound thereby creating an electrical current or voltage that passes through either the wound or peripheral tissue.
This form of accelerated wound healing has been the subject of many clinical trials over recent years which have culminated in health insurance companies (such as
CIGNA) recognizing it as a genuine treatment and agreeing to compensate incurred treatment costs. The phenomenon of acceleration of electrical wound healing by electrical currents was reported 150 years ago by the German physiologist Emil Du Bois-Reymond.
Josef Penninger of the Austrian Institute of Molecular Biotechnology in Vienna and Min
Zhao of the University of Aberdeen, UK, have demonstrated that natural electric fields and currents in tissue play a vital role in orchestrating the wound-healing process by attracting repair cells to damaged areas. Researchers have also identified the genes that control the process (" 'Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-γ and PTEN", Nature, vol 442, p 457, 27 JuI 2006).
While the effects of ES have been known for several decades it is only recently that the mechanism behind the effect is being revealed. This process has been termed electrotaxis and has been observed by several other authors. In particular a publication from
Huttenlocher (NEJM 356(3), 2007) clearly shows the movement of a cell under the influence of an electrical field. The movement is directed towards the cathode.
Wound healing is a complex process with several distinguishable stadia (cf: Gurtner et al, Wound repair and regeneration, Nature Insight 453, 314-321 (2008)). In general it can be categorized into the following four healing phase conditions:
1. The necrotic condition refers to the wound healing phase condition where catabolic processes have been resulting in dead tissue.
2. The fibrinous slough or infection condition refers to the circumstance where the wound is in the inflammatory phase, where dead cellular debris fills the base of the wound with an off-white to yellow layer,
3. The granulation condition refers to the healing phase when the wound has reached the proliferative stage of healing and when the wound cavity is slowly filled with the "repair-material" of the body which consists of fϊbro -vascular tissue and is called granulation.
4. The epithelialisation condition describes the wound healing phase wherein the keratinocytes (epidermal cells) are dividing and gradually crossing the wound surface from the margins towards the opposite side. Once the cells make contact with each other the cells stop dividing (contact inhibition).
Normal treatment of wounds is predominantly based on controlling the moisture conditions around the wound. A moist wound environment has been shown to promote re-epithelialisation and healing, as shown by Winter, Formation of the Scab and the Rate of Epithelialisation in the Skin of the Domestic Pig, Nature 193, 293-294 (1962); and Kan et al, The Role of Moisture Balance in Wound Healing, Advances in Skin & Wound Care, 20 (1), 39 (2007). Exposing wounds during healing to air dries the surface of the wound and might impede the healing process. However, the wound environment should also not be too wet as this may cause maceration and may enhance the risk of bacterial infection. Numerous commercial products that support a moist wound healing environment are available. Dressings that maintain a moist wound may be, for instance, based on hydrocolloids that are applied directly over the wound. This dressing is impermeable to oxygen, moisture and bacteria. Alternatively, absorptive dressings can be utilized. They are not pre -moisturized but rather absorb moisture from exudates in the wound to keep a moist environment. Normally, they can absorb up to 20 times their weight and may be especially suited for wounds with large amounts of exudates. Calcium alginate dressings such as
Sorbsan® or Kalostat® are two types of soft, fibrous absorptive dressings that are derived from seaweed. U.S. Patent 6,915,950 discloses methods that record the wound conditions in relation to moisture conditions.
In order to avoid infections, a gradual release of disinfectants is sometimes helpful to support wound healing. Suitable disinfectants are saline or silver sulfadiazine (e.g. Silvadene®). In general, administration with systemic antibiotics is not warranted unless the patient is demonstrating signs of a systemic infection. In that case the goal of antibiotic treatment is not wound sterilization, but rather control of bacterial growth. Often ointments containing a number of topical agents including sugar, antacids, vitamins A and D are used. The research supporting the effectiveness of these ointments is not clear and often their function can mainly be ascribed to moisturizing the wound environment. Wound healing is reported further to be promoted by addition of steroids such as estrogens and comparable products such as dehydroepiandrosterone (DHEA). See, e.g., Ashcroft et al, Topical estrogen accelerates cutaneous (skin related) wound healing in aged humans associated with an altered inflammatory response, Am J Pathol. 155 (4), 1137-1146 (1999).
Controlling moist conditions is obviously important for wound healing. However, controlling the hydration conditions over a longer period is a problem. This is normally done by regular renewal of the moisturizing ointment. The ointment is filled with particles which are loaded with water, and eventually other additives, which may be released in time. The particles may be embedded in viscous liquids such as peptide mixtures, glycerine, etc. The emission of water from the particles is high at the onset, but decreases in time. Alternatively semi-solids, such as gels, are used to cover the wound. See U.S. Patent 5,905,092 which describes a composition with water loads of more than 60%. Also, here the water content offered to the wound decreases with time and, in order to create acceptable average conditions, is too high at the onset and too low at the end, before renewal of the composition. Another limitation often not addressed is that, under certain conditions, the wound might be exuding moisture by itself, thereby increasing the moisture conditions to an excessive level. Also, over time, as the wound healing process approaches fmalization, the ideal moisture concentration will change, though at the end of the healing process the maintenance of moisture control is less important.
It would therefore be beneficial to have a means, e.g., in the form of a special plaster, gel, ointment or other composition, that allows for controlling the moisture conditions over time by measuring the moisture concentration associated with a wound and subsequently releases or uptakes moisture to maintain optimal moisture levels. In addition, it would be supportive for wound healing if the same means can be used to emit disinfectants/antibiotics or wound-healing promoters, such as steroids. It would be even more supportive for wound healing if the moisture content could be locally regulated, e.g.,
providing a water load or moisture content at the periphery of the wound that is different from the center of the wound. A proposal was addressed by McCoIl et al, Real-time monitoring of moisture levels in wound dressings in vitro: An experimental study, International Journal of Surgery, 5 (5), 316-322 ( 2007). However, they propose a patient - inconvenient method based on sensors placed at the wound/dressing interface and a fluid injection path to moisturize a foam-type wound coverage.
There are several problems with prior art ES:
In the trials of ES that have so far been carried out one of the main problems is skin irritation and in extreme cases, skin burning. This is caused by too much current being locally drawn by the electrode section situated on top of the wound. If the wound or an adjacent area of skin has a low conductivity then the majority of current passes through this point, causing Joule heating and burning.
In existing devices, there is little lateral movement of cells due to the electrical current. The only movement is upwards from the stratum directly below the wound. There is no monitoring of the wound and the healing process.
It has been shown that some waveforms are more effective for ES than others. These waveforms are limited to variations of the applied current in time. There are no possibilities to create any spatial variations, such as lateral electrical field patterns and currents directed towards the perimeter of the wound. Such waveforms could prove more efficient in accelerating healing.
There is therefore a need for an improved device for electrical stimulation of a skin wound and for an improved method of electrical treatment of skin wounds.
SUMMARY OF THE INVENTION The present invention provides a device for electrical treatment of a skin wound comprising a flexible substrate adapted for attaching to the skin wound and the surrounding skin, a matrix of electrodes, means for determining the presence of the wound and/or its perimeter and/or and means for applying a voltage between the wound and its surrounding. The means for determining the presence of the skin wound may comprise one or more sensors for detecting the real-time state of the skin wound.
A "skin wound" according to the present invention may be any injury, burning or lesion of the skin including irritations and inflammations. In particular, ES is preferably
applicable in case of chronic wounds such as stage III or stage IV pressure ulcers, arterial diabetic ulcers and venous static ulcers.
According to a preferred embodiment, the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the electrodes at and/or close to the wound are charged opposite with respect to the electrodes surrounding the wound or its perimeter at a predetermined distance. For example, the electrodes around and on top of the wound may be made negative and other electrodes further away may be made positive, or vice versa. Alternatively a counter electrode may be incorporated in the patch. In one preferred embodiment, the electrodes further away are chosen at a fixed distance from the perimeter of the wound, wherein the number of positive electrodes equals the number of negative electrodes. Naturally, a voltage between the wound and its surrounding may as well be achieved by different means. In general, the electrodes at and/or close to the wound and the electrodes surrounding the wound or its perimeter at a certain distance have to be set on different electric potentials. For instance, the electrodes around and on top of the wound may be grounded and other electrodes further away may be set on a positive potential.
More complex patterns of charge or potential may also be applied. It is, e.g., preferred that the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the electric potential gradually increases or decreases from the electrodes at and/or close to the wound towards the electrodes surrounding the wound or its perimeter at a predetermined distance. This may be achieved by providing several rings of electrodes which are set on different electric potential. In another preferred embodiment, a gradient in voltage from the electrodes in the most outer regions of the matrix towards the electrodes situated near or on top of the wound is applied. Of course, the gradient may alternatively be directed from the center towards the periphery. It is preferred that the device further comprises means for measuring the electric current caused by the applied voltage. Furthermore, the means for applying a voltage is adapted to control the matrix of electrodes in such a way that the measured current does not exceed a predetermined threshold. It is thus prevented that skin under the electrodes is irritated or even burned due to excessively high currents, which can cause Joule heating and consequently burning of skin.
The presence/location of the wound and/or its perimeter may be determined by measuring the impedance between each electrode and its neighboring electrodes. The voltage to be applied between at least some of the electrodes is then determined or calculated by an on-board or external control module in response to the location of the wound and/or its
perimeter. Preferably the device is adapted for repeatedly determining the location and/or perimeter of the wound and readjusting the applied voltage pattern in predetermined time intervals. For instance, some wounds tend to heal from the perimeter towards the center. Accordingly, the largest voltage should be applied at the perimeter of such wounds. After some progress in healing the wound may be smaller and its perimeter may have migrated. Thus, the applied voltage pattern has to be re-adjusted in predetermined long-time intervals.
The means for applying a voltage may also be adapted to apply a varying voltage over short time intervals. For example, short DC current pulses may be applied, which travel towards the wound. Alternatively, AC electric fields may be used utilizing the effect of dielectrophoresis to stimulate the movement of cells towards the wound. Preferably, the voltage is between 1 V and 10 V and the frequency between 10 kHz and 100 kHz.
According to a preferred embodiment, the matrix of electrodes may be coated with a therapeutical agent. The therapeutical agent may comprise one or a combination of the following substances: growth factors, e.g. epidermal growth factors, polymer or lipid micells and/or vesicles suitable for drug delivery, corticosteroid-based drugs, anti-inflammatory proteins. If the electrodes, e.g., are coated with an epidermal growth factor and a gradient in voltage towards the wound is applied, the growth factor is "injected" into the wound. This should promote cell migration and accelerate healing.
Alternatively, the composition of vesicles, in particular of transport vesicles, can be tailored to encase therapeutic agents such as drugs or growth factors while the surface of the vesicle can be tailored to a specific charge. Hence such a "drug delivery" vesicle can be designed such that it responds to the electrical fields in a distinct manner from the natural environment (i.e. say inflammatory inducing cells). This can ensure the movement and localization of only said drug delivery vesicle, whilst leaving the surrounding tissue unperturbed.
Naturally, the type of therapeutical agent being suitable strongly depends on the type of wound. For instance, persisting inflammations (i.e. non-open wounds, with swelling, necrosis and inflammation) are often treated with inflammation suppression drugs. Such drugs act to suppress the localization and/or activation of immuno-cell at the sites of inflammation. Nonetheless, these drugs are not recommended for long term use, due to side effects and cellular adaptations. Much like cells can be stimulated electrically to migrate towards a source, one can also "repel" cells electrically and chemically. As described above, an electrically active patch can be applied over an inflamed area and the electric fields tuned to repulse inflammatory cells. This may provide a superior option to corticosteroid based
drug therapies, since the negative effects of long term use would be ablated. In addition, as described above, the electric patch can also be used to create a locally defined gradient of chemo-repellant either via a charged drug, or anti-inflammatory protein, or via a complex drug delivery vehicle. Preferably, the device according to the present invention comprises large area electronics on a polyimide release layer. However, the invention is not limited thereto and any type of flexible substrate suitable to be attached to skin may be used in combination with any matrix of electrodes.
In addition temperature sensors can be integrated into the electrically active patch so that the temperature of the wound can be measured. This is advantageous for detecting the presence of an infection as the skin temperature typically increases from 32°C to 37°C when a wound becomes infected. These sensors can also be formed in an array to allow a temperature map of the wound to be created. Most preferably the electrode geometry and material are chosen so that the electrode pad functions as both a resistive temperature sensor, a means for measuring impedance, and also for applying the voltage or current for healing.
In addition heaters can be integrated into the active patch so that the temperature profile over the wound can be controlled to influence the healing process.
Alternatively the moisture of the wound can also be measured via the electrically active patch and this measurement used to monitor the healing process.
Alternatively the active patch can use high frequency radiation, such as THz radiation, generated locally on the patch to monitor the healing process.
The present invention further provides a method for electrical treatment of a skin wound comprising the following steps: placing a matrix of electrodes attached to a flexible substrate on top of the skin wound; determining the presence of the wound and/or its perimeter; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance.
Preferably, the electric potential gradually increases or decreases from the electrodes at and/or close to the wound towards the electrodes surrounding the wound or its perimeter at a predetermined distance.
As already outlined with respect to the device, the steps of determining the location and/or perimeter of the wound and applying a potential to the electrodes are preferably repeated in predetermined time intervals in order to adjust the resulting applied voltage/current to the actual status of the wound and its progress in healing. The step of
determining the location and/or perimeter of the wound may be performed by measuring the impedance between each electrode of the matrix and its neighboring electrodes. Since wounded skin has a different conductivity compared to healthy skin, the local impedance allows for determining the location of the wound. The inventive method further comprises the step of measuring the current between the electrodes. The potential applied to the electrodes is controlled in such a way that the measured current does not exceed a predetermined threshold in order to avoid irritation or burning of the skin due to excessively high currents.
According to a preferred embodiment, the electric potential applied to the electrodes is varied over time. For instance, an AC field is applied between the electrodes, wherein the voltage of the AC field is between 1 V and 10 V and the frequency is between 10 kHz and 100 kHz.
As outlined above, the matrix of electrodes is preferably coated with a therapeutical agent, which may comprise one or a combination of the following substances: a growth factor, e.g., an epidermal growth factor, polymer or lipid micells and/or vesicles suitable for drug delivery, corticosteroid-based drugs, anti-inflammatory proteins.
The device and method according to the present invention provide several advantages over the prior art. Since the current applied during the therapy or stimulation is measured and controlled, skin irritation or even burning can be avoided. A considerable lateral movement of cells may be achieved due to the applied currents. The wound and its process of healing can be monitored during the therapy or stimulation. Accordingly, at every stage of healing the patch of electrodes may be controlled in response to the actual status of the wound. Due to the matrix technology any type of field or waveform can be applied allowing for an enormous versatility of the inventive device. In accordance with a preferred embodiment of the invention, the device for treatment of a skin wound includes a flexible substrate adapted for attaching to the skin wound and the surrounding skin, a matrix of electrodes, a means for determining the presence of the wound and/or its perimeter and/or means for electrically monitoring the water content and controlling a liquid load between the matrix and the wound, and means for applying a voltage between the wound and the surrounding skin. As mentioned above, the measurement and control of the water content in and around a wound is very important for proper healing of the wound. The matrix of electrodes may include a single electrode, and/or multiple electrodes. The single electrode arrangement presents a simple mechanical arrangement, but may require a more complex electronic driving scheme. The matrix of electrodes may be
selected from the group consisting of interdigital electrodes, patterned electrodes and transistor- or diode-driven patterned electrodes.
In another preferred embodiment, the means for controlling a liquid load between the matrix and the wound includes a plurality of load-uptaking material, such as a plurality of miniaturized liquid-containing elements. This may include a hydrogel material which is adapted to absorb a liquid load, and is adapted to release the liquid load in response to an electrical stimulation from the matrix of electrodes.
In another preferred embodiment, the plurality of load-uptaking material is arranged within an ointment. The liquid load may be selected from the group consisting of water, buffer salts, disinfectant, saline, silver sulfadiazine, healing steroids, or combinations thereof. A plurality of different liquid loads may be in the plurality of separate load-uptaking materials. This arrangement provides for each of the different liquid loads to be released selectively, depending on the wound conditions.
In a preferred embodiment, a method for electrical treatment of a skin wound comprising the steps of placing a matrix of electrodes attached to a flexible substrate on top of the skin wound and the surrounding skin; determining the presence of the wound and/or its perimeter and/or electrically monitoring the water content and controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance. The selective application of electric potential to selected areas on or about the wound promotes faster and more effective healing.
In another preferred embodiment of the method, the steps of determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance are repeated in predetermined time intervals. The same pattern is not necessarily repeated endlessly, but a pattern of electric potential may be applied repeatedly in response to the condition of the wound and the determination of the water content in or around the wound.
In another preferred embodiment, the step of electrically monitoring the water content between the matrix of electrodes and the wound includes measuring an electrical property between each electrode of the matrix and its neighboring electrodes. The electrical property may be selected from the group consisting of impedance, conductance and capacitance.
In another preferred embodiment the steps of controlling a liquid load between the matrix of electrodes and the wound, and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance results in the release of the liquid load from a plurality of load-uptaking materials between the matrix of electrodes and the wound. Different load-uptaking materials may be used, wherein each of the different material requires a distinct electrical signal or condition to release the liquid load contained therein.
With the inventive device and method there are many possibilities for influencing the way a wound heals. In many cases the focus will be purely on accelerating healing of chronic wounds, but there may also be driving schemes which are suitable to reduce or avoid scarring. This could extend the application of the device from the area of chronic wounds to scar avoidance post-surgery, for example in cosmetic surgery.
These and other aspects of the invention will be apparent from and elucidated with reference to the embodiment(s) described hereinafter.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows a flexible array of electrodes in a device for treatment of a skin wound, in accordance with an embodiment of the invention;.
Fig. 2 schematically illustrates an arrangement for operation of electrodes in a device for treatment of a skin wound, in accordance with an embodiment of the invention;
Fig. 3 illustrates an applied voltage gradient directed towards a wound, in accordance with an embodiment of the invention;
Fig. 4 shows a traveling wave driving towards a wound, in accordance with an embodiment of the invention; Fig. 5 shows a low field driving towards a wound, in accordance with an embodiment of the invention;
Fig. 6 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material applied to a wound, in accordance with an embodiment of the invention; Fig. 7 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material or a polymer or solid gel with load-uptaking and releasing properties between the electrodes applied to a wound, in accordance with an embodiment of the invention;
Fig. 8 illustrates a sectional view of a flexible matrix having an ointment with load-uptaking material applied to a wound, including dedicated interdigitated electrodes for determining local water content of the wound, in accordance with an embodiment of the invention; and Fig. 9 shows a schematic view of a device for measuring conductivity and/or thermal heat capacity for determining water content associated with a wound, in accordance with an embodiment of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS Fig. 1 shows a flexible array 1 of electrodes 2 as now for instance also used in displays. Such flexible arrays, e.g., patch or matrix, 1 can be made from large area electronics technology on a polyimide release layer, which is often referred to as EPLAR. Similar technologies may be applied for the device according to the present invention.
Fig. 2 schematically illustrates how a device according to a preferred embodiment of the present invention is used. A patch or matrix 1 of electrodes is placed on top of the wound 3 (see Fig. 2(a)). The electrodes 2 are then scanned and the impedance between each electrode and its neighbouring electrodes is measured. Since wounded skin will have a different conductivity compared to healthy skin, the presence and location of a wound 3 and therefore its perimeter can be determined. As indicated in Fig. 2(b), the electrodes 2b around and on top of the wound may be charged with an electrical potential, e.g., negatively charged. Other electrodes 2a, further away from the wound, may be made positive, or vice versa. There are several options for this, but the most simple arrangement is to charge the electrodes 2a at a fixed distance from the perimeter of the wound 3 positively and to charge the same number of electrodes negatively as were made positive. The current or voltage waveform is applied for a fixed period of time. The resulting current from the positive electrodes 2a to the negative electrodes 2b is indicated with arrows in Fig. 2(c). The amount of current that can be supplied via each segmented electrode is limited to avoid burning. If too large a current is to be supplied between two electrodes 2a, 2b, then the current is redistributed to neighbouring electrodes. The step of scanning the electrodes is repeated and the size and conductivity of the wound is compared to the previous measurement(s). The current or waveform can then be adjusted accordingly to enhance healing. Alternatively, the monitoring is not done via measuring the drawn current, but by measuring the impedance of the skin under each electrode. This is done at either a pre-determined frequency or by performing a frequency
sweep. From the impedance data the state of the wound, e.g., both size and stage of healing, can be extracted and compared to previous measurements.
As an alternative to the embodiment shown in Fig. 2, it may be preferred not to create only one ring of positive electrodes but to create a gradient in voltage from the electrodes 2a in the most outer regions of the patch towards the electrodes 2b situated near or on top of the wound, as illustrated in Fig. 3. For example, several rings 4a to 4f may be set on different potentials with the potential gradually increasing or decreasing from the center of the wound to the periphery of the patch or matrix 1.
As mentioned above, such an array patch 1 allows for the generation of time- variable in-plane electrical fields. This creates many new methods for driving the electrodes which were not possible in the case of mono-electrode patches. For example, it has been shown that applying a short DC current pulse is effective for healing. With such an array patch it is possible to create a pulse on an electrode and to allow this pulse to travel towards the wound. Alternatively it is also possible to apply AC electric fields instead of DC fields. The physical effect of dielectrophoresis could then be used to stimulate the movement of cells towards the wound or to spread the cells to provide an array of nucleation sites from which the wound healing initiates thus controlling, among others, scar formation. The voltage applied is typically a few volts and in the frequency range of 10-100 kHz. For example, a so called travelling wave driving waveform can be seen in Fig. 4 where different phases of sine wave voltage are applied to electrodes which surround the wound. This type of driving is, however, not the most effective if the cells are in a saline environment, as may be the case on a wound. Thus, in the alternative, one may use a low field driving scheme, wherein an area of low electrical field is created and moved in the direction of the wound. This is illustrated schematically in Figs. 5(a) to 5(d).
In the embodiments described above, the migration of cells to the wound has been a purely electrically driven process. It is, however, also possible to envisage a process which is indirectly driven by an electrical field, but is of chemical nature. Cell migration in the body is usually driven chemically and is referred to as chemotaxis. The cells at inflammation sites excrete various proteins which include cellular growth and differentiation factors. Specific cell types, e.g., immune cells, or stem cells, respond to these chemically- excreted signals and migrate towards the source. If a gradient in growth factor could be created towards the wound then this would also promote cell migration.
Charged molecules, such as drugs or proteins, can be given to a patient transdermally via a process called iontophoresis. This involves applying an electrical field through the skin and "pulling" the charged drug particles into the patient. This is becoming a popular method for sustained drug delivery. According to a preferred embodiment, the electrodes are coated with a growth factor such as EGF (epidermal growth factor) and a gradient in voltage towards the wound is applied (such as in Fig. 3). This will "inject" the growth factor into the skin with a gradient which is determined by the voltages applied to the segmented electrodes. The growth factor gradient is therefore in the direction of the wound and should therefore promote cell migration and accelerated healing.
In addition there have been a lot of developments recently in the area of drug delivery using polymer and lipid micells and vesicles. The composition of these vesicles can be tailored to encase drugs (or growth factors) while the surface of the vesicle can be tailored to a specific charge. Hence, such a "drug delivery" vesicle can be designed such that the vesicle responds to the electrical fields in a manner distinct from the response of the natural environment, i.e., inflammatory inducing cells. This can ensure the movement and localization of only said drug delivery vehicle, whilst leaving the surrounding tissue unperturbed.
The stimulated migration of cells towards damaged tissue can have great benefits with respect to healing and tissue repair. Likewise, persisting inflammations, i.e., non-open wounds, with swelling, necrosis and inflammation, are often treated with inflammation suppression drugs. Such drugs act to suppress the localization and/or activation of immuno -cells at the sites of inflammation. Nonetheless, these drugs are not recommended for long term use, due to side effects and cellular adaptations. Similar to the manner in which cells can be stimulated electrically to migrate towards a source, one can also "repel" cells electrically and chemically. Similar to the embodiment described above, the electrically active patch or matrix 1 can be applied over an inflamed area and the electric fields tuned to repulse inflammatory cells. This may provide a superior option to corticosteroid-based drug therapies, since the negative effects of long term use would be ablated. In addition, as described above, the electrically active patch 1 can also be used to create a locally defined gradient of chemo-repellant either via a charged drug, or antiinflammatory protein, or via a complex drug delivery vehicle.
In addition, temperature sensors can be integrated into the electrically active patch 1 so that the temperature of the wound 3 can be measured. This is advantageous for
detecting the presence of an infection as the skin temperature typically increases from 32°C to 37°C when a wound 3 becomes infected. These sensors can also be formed in an array to allow a temperature map of the wound to be created. Most preferably, the electrode geometry and material are chosen so that the electrode pad functions as both a resistive temperature sensor, a means for measuring impedance, and also for applying the voltage or current for healing.
In addition, heaters can be integrated into the active patch 1 so that the temperature profile over the wound 3 can be controlled to influence the healing process.
Alternatively the active patch can use high frequency radiation, such as THz radiation, generated locally on the patch to monitor the healing process.
In an alternative embodiment, or as a stand-alone solution, the moisture of the wound 3 can also be measured via the electrically active patch 1 and this measurement may be used to monitor and manipulate the healing process.
The maintenance of proper moisture levels in and around the wound as it heals is very important. The moisture, e.g., water, content must be measured, as a first step so that it can be adjusted or controlled. Towards that goal, a device for the treatment of a skin wound 3 includes a flexible substrate 1 adapted for attaching to the skin wound 3 and the surrounding skin, a matrix 1 of electrodes 2, means for determining the presence of the wound 3 and/or its perimeter and/or means for electrically monitoring the water content and controlling a liquid load between the matrix 1 and the wound 3, and means for applying a voltage between the wound 3 and the surrounding skin. As mentioned above, the measurement and control of the water content in and around a wound is very important for proper healing of the wound. The matrix 1 of electrodes 2 may include a single electrode, and/or multiple electrodes. The single electrode arrangement presents a simple mechanical arrangement, but may require a more complex electronic driving scheme.
The device electronically monitors the water concentration in and around the wound 3 and electrically stimulates the release or absorption of water, disinfectants and/or treatment drugs in a measure -response-feed-back cycle. The electrode array is a single- electrode or multiple-electrode arrangement which may consist of interdigital electrodes, patterned electrodes, transistor or diode driven patterned electrodes. Interdigital electrodes are electrodes of different types or arrangements which are woven or arranged very closely together so as to be effectively inseparable and to provide the possibility for a number of different types of simultaneous measurements and the application of different electrical potentials simultaneously, or nearly so, in a single matrix 1 array. Preferably, interdigitated
electrodes or electrode arrays are used in one embodiment. The electrode array 1 functions to provide local detection and quantification of water in and around the wound 3. The electrode array 1 also functions to release water or other substances, e.g., a liquid load, from miniaturized water containers accommodated in an ointment between the electrode array 1 and the wound 3.
In another preferred embodiment, the means for controlling a liquid load between the matrix 1 and the wound includes a plurality of load-uptaking material, such as a plurality of miniaturized liquid-containing elements. This may include a hydrogel material which is adapted to absorb a liquid load, and is adapted to release the liquid load in response to an electrical stimulation from the matrix 1 of electrodes 2. A plurality of load-uptaking material is meant to include a number of identical or dissimilar discrete load-uptaking elements within an ointment, or a generally solid gel or polymer, which may be homogeneous in composition, having load-uptaking and releasing properties and generally corresponding to the number of identical or dissimilar discrete load-uptaking elements. In another preferred embodiment, the plurality of load-uptaking material is arranged within an ointment. The liquid load may be selected from the group consisting of water, buffer salts, disinfectant, saline, silver sulfadiazine, healing steroids, or combinations thereof. A plurality of different liquid loads may be in the plurality of separate load-uptaking materials. This arrangement provides for each of the different liquid loads to be released selectively, depending on the wound conditions.
There are several suitable miniaturized water-containing materials, e.g., hydrogel materials, that can be loaded with water by swelling and which may be directed to release their water load by electrically-stimulated de-swelling, e.g., contraction, shrinking. The liquid load may be as simple as water, or it may be water that contains buffer salts to make it more physiologically normalized. However, the liquid load may also contain disinfectants or antibiotics such as saline, silver sulfadiazine or steroids that promote healing, such as estrogens. Combinations of these materials may also be used.
Direct information regarding the water concentration and water distribution over, on or around the surface of the wound 3 may be obtained from high frequency impedance/conductance or capacitive measurements through the electrodes at the various locations of the device-wound interface. This measurement is not trivial given the complex composition of the various components and the presence of ion-rich water-containing materials. Of direct interest is the amount of water concentrated at or near the interface with the wound 3. Some detailed solutions will be provided in the next section. Alternatively,
single-electrode methods may be used to make the design of the water-releasing element more simple, but may be more complicated in an electronic sense.
In a preferred embodiment, a method for electrical treatment of a skin wound comprising the steps of placing a matrix 1 of electrodes 2 attached to a flexible substrate on top of the skin wound 3 and the surrounding skin; determining the presence of the wound 3 and/or its perimeter and/or electrically monitoring the water content and controlling a liquid load between the matrix 1 of electrodes 2 and the wound 3; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance. The selective application of electric potential to selected areas on or about the wound promotes faster and more effective healing.
In another preferred embodiment of the method, the steps of determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance are repeated in predetermined time intervals. The same pattern is not necessarily repeated endlessly, but a pattern of electric potential may be applied repeatedly in response to the condition of the wound and the determination of the water content in or around the wound.
In another preferred embodiment, the step of electrically monitoring the water content between the matrix of electrodes and the wound includes measuring an electrical property between each electrode of the matrix and its neighboring electrodes. The electrical property may be selected from the group consisting of impedance, conductance and capacitance.
In another preferred embodiment the steps of controlling a liquid load between the matrix of electrodes and the wound, and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance results in the release of the liquid load from a plurality of load-uptaking materials between the matrix of electrodes and the wound. Different load-uptaking materials may be used, wherein each of the different material requires a distinct electrical signal or condition to release the liquid load contained therein. As shown in Fig. 6, in a first preferred embodiment the load-uptaking material
6 is present as particles in an ointment 5. The load-uptaking material 6 may be a swelling polymer made by lithographic means or by replication processes, e.g., as described in [M.H.M. Oudshoorn, R. Penterman, R. Rissmann, J.A. Bouwstra, D.J. Broer, W.E. Hennink, Preparation and Characterization of Structured Hydrogel Microparticles Based on Cross-
Linked Hyperbranched Poly 'glycerol, Langmuir 23 (23), 11819-11825 (2007)], although for this specific application other materials of a different chemical nature may be selected. Suitable materials may include copolymers made from acrylamide and acrylic acid crosslinked by small amounts of bisacrylamide. These materials may be made by photopolymerization of the monomer mixtures and loaded with water and other components. Upon the application of an electrical field these copolymers are know to contract (de-swell) at the anode side thus releasing their load, as illustrated in Fig. 6 and in [Tanaka, T., Nishio, L, Sun, S. -T., and Ueno -Nishio, S., Collapse of gels in an electric field, Science 218, 467-469 (1982)]. By reversing the cathode and anode, the opposite part can be contracted to release its liquid load. The loaded particles may be embedded in a viscous base material, e.g., glycerol, polyethylene glycol oligomer, mixture of proteins, etc., to make an ointment as schematically shown in Fig. 6. Preferably, the viscous base material is electrically (ionic) conductive and transparent for water diffusion to some extent. Flaked materials as liquid-loaded materials are of special interest because they simplify the manufacturing of ointments. In another embodiment, different liquid-bearing particles 6 may be filled with different liquid loads or fluids, e.g., first particles 6 loaded with water or physiological salt solution and a second particles 6 loaded with antibiotics/disinfectants. These different liquid- bearing particles 6 may be triggered by different stimuli, e.g., different voltages. This arrangement provides the possibility for different fluids or liquid load to be release at different times, in a controllable manner. One fluid, e.g., water, could be continuously applied, whereas the second fluid, e.g., disinfectant, could be released for a short time every couple of hours to keep the wound sterile.
As mentioned above, the use of flake material for liquid-loading may be desirable because: 1. Ointments may be easily made from such materials, and
2. A blend of different flakes may be used, i.e., with different liquid-loading, e.g., water and water plus drug, or having different electrical or thermal response.
In another preferred embodiment, the ointment 5 containing the loaded hydrogel material 6 is applied as a coating in between electrodes 2 of the electro- stimulating device, as is illustrated in Fig. 7. The hydrogel ointment 5, or a gel or polymer having liquid- uptaking and releasing properties, may be embedded in small notches in the matrix 1 to generate more volume. Before the use of the device, the hydrogel material 6 is loaded with the liquid-loading/healing-promoting ingredients. As explained above, this liquid load can be as simple as water, or it can be water-containing buffer salts to make it more physiologically
normal. It may also contain disinfectants such as saline, silver sulfadiazine or healing- promoting steroids, such as estrogens. Combinations of these materials may be used as well. In another preferred embodiment, the device may include a stack of multiple layers which may be applied onto the wound 3. A first layer of the stack, which may be in contact with the wound 3, may comprise a plurality of hydrogel 6 aggregates or hydrogel flakes for triggered release of the substances as described above. A second adjacent layer in contact with the first layer and the electrodes 2, which may also separate the electrodes 2 from each other, may include an anti-adhesive property to prevent the wound tissues from sticking and promote new tissue formation. In this way the electrodes 2/electrode array 1 may be removed easily when healing is complete. The second layer could be a hydrogel ointment 5, 6 layer as well but with additional ingredients, e.g., immobilized antifouling agents. In another preferred embodiment, each of the stored agents/liquid load materials 6 may be released on command, i.e., each different type of load-uptaking material 6 may be release at a different moment in time. Toward this end, different types of hydrogels and load-uptaking materials may be applied, each of which may be separately triggered to start and/or stop release of said agent/load uptaking materials 6.
In a first example, corresponding to the embodiment illustrated in Fig. 6, the hydrogel particles 6 were made by copolymerizing a mixture of: 80 wt-% acrylic acid, 16 wt- % sodium vinyl sulfonate; 2 wt-% N ',N '-methylene bisacrylamide; and 2wt-% 2-Hydroxy-2- methyl- 1 -phenyl- 1-propanone Irgacure 754 - from Ciba Specialty Chemicals.
The mixture was applied in a nickel mould that was provided with a release agent. The mould included a number of small containers of approximately 50x50x5 μm and the mixture was cured by UV light. After fully cured, the polymer flakes were released from the mould by moderate bending. The flakes were saturated with an aqueous NaCl solution by immersion for 2 days at 25 0C. Subsequently, a mixture was made of 70 wt-% of the saturated particles with 30 wt-% of mixture containing 3 parts glycerol and 1 part chitosan. The ointment 5 that is formed is applied between the wound 3 and the device containing the multi electrode array 1, as illustrated in Fig. 6. The hydrogel 6 flakes start to release water at a DC voltage of 3 Volts. It is desired to uncouple the electro -stimulated release of water or other ingredients from the electrical field or current that is utilized for electro-stimulated wound healing. The solution is to use an alternating current for the electrical wound healing stimulation and a direct current for water/drugs release from the hydrogel materials 6. Of course, in the absence of a DC field the hydrogel material 6 tends to start uptaking water
again. This is a slow and diffusion-controlled process. To prevent the dehydration of the ointment, the DC voltage should be repeated intermittently in coordination with the AC fields used to stimulate wound healing. An appropriate sequence of DC and AC field-addressing is therefore part of the invention. In another example, corresponding to the embodiment illustrated in Fig. 7, a mixture is made containing: 1 gram hyaluronic acid; 5 ml 1 N NaOH solution; and 0.55 ml of 0.8 g/1 ethylene glycol diglycidyl ether in ethanol.
After degassing, the mixture is poured onto an electrode array 1 where the solution fills the gap between the electrodes 2. The mixture is allowed to react at 60 0C where the hyaluronic acid crosslinks. The formed gel is removed from non-reacted components by placing it in an excess of distilled water for 3 days and dried. Then the gel is loaded by a 1 g/1 solution of estrogen in water over 3 days contact. The electrode structure havine the loaded hydrogel between the electrodes 2, as shown in Fig. 7, is manipulated by applying an AC field for electrical stimulation of wound healing and a DC field for drugs and water release in an alternate basis.
With respect to the measurement of water concentrations, special precautions should be taken and particular device designs are required. With respect to the high frequency impedance measurements for the purpose of measuring water content near the matrix 1 /wound 3 interface, the utilization of high frequency impedance measurements should be made so as to exclude water response due to the presence of the responsive hydrogels 6 between the detection electrodes 2. A solution is shown in Fig. 8. This arrangement provides an example of dissimilar interdigitated electrodes incorporated into a single matrix 1. Numerous variations are possible, whereby numerous measurements may be taken to determine various conditions in or around the wound simultaneously, while numerous dissimilar electric potentials may be applied in different areas of the matrix 1, as a result of the measurements. Though this arrangement may include the risk of a delay between the measured water concentration and the actual water concentration, through the miniaturization of the water measurement electrodes 7 the delay time can be reduced. Instead of paired electrode sets 7 for measuring water concentration, an interdigital array of electrodes may also be used. Examples thereof, e.g., for measuring water contents of oil or paper pulps, are given in literature. Cf. Sundara-Rajan et al, IEEE Sensor Journal (2004).
An insulating dielectric 8 may be included between the water measurement electrodes 7. The insulating dielectric 8 may be a polymer that is applied by lithographic
means. In one embodiment the top of the water detection electrodes 7, together with the insulating dielectric 8 may be covered with a thin membrane, e.g., SiO2, in accordance with the principles of fringe field detection [Cf. Mamishev et al, Inter digital sensors and transducers, Proc. IEEE 92, 808 (2004)]. A single electrode capacitance probe is described by Schϋller et al,
Measurement of Water Concentration in Oil/Water Dispersions with a Circular Single- Electrode Capacitance Probe, IEEE Trans. Instr. Meas. 53 (5), 1378 (2004), and is based on the measurement of capacitance by utilizing the effect the dielectric constant has on the frequency of an oscillator 9. At the specific places in the electrode array 1 that direct the hydrogels 6 to release water oscillator electrical circuits 9 may be integrated to provide capacitive water measurement. The oscillator circuit 9 is illustrated in Fig. 9. This oscillator 9 may operate at a frequency of approximately 20 MHz. The wound 3 and fluid that is present in the vicinity of the capacitor plate 10 affects the oscillating frequency of the circuit 9. This change in frequency is related to an equivalent change in the dielectric permittivity of the mixture. If a gas is present adjacent to the capacitor plate 10, no reduction in frequency is observed, while if pure water is present adjacent to the capacitor plate 10, a much larger reduction in frequency is observed.
The operating frequency ω of the oscillator 9 depends on the inductance of the coil of the oscillator circuit L and the capacitance Cm of the medium located near the electrode
[Hz] ω at - (1)
JLC m
The capacitance change of the medium outside the electrode is related to the operating frequency change of the oscillator as follows:
*c- [F] The capacitance is related to the dielectric permittivity as follows:
C.C-4 [F] (3)
where Eo is the dielectric permittivity in vacuum, ε is the dielectric permittivity, A is the area of the capacitor, and d is the distance between the capacitor plates. Thus,there is a proportional relation between the capacitance and dielectric permittivity. Only the frequency shift of the oscillator is recorded, not the loss. The Cm in the equation includes all capacitive influence that contributes to the frequency shift (circuit components, media impedance, etc.). A capacitance value that represents the measured media is then calculated. The length of the electrode is very small compared to the wavelength of the oscillator so the electrode impedance is very high and capacitive.
The range of Cm is highly dependent on the size (area) and shape of the electrode and of the shape (thickness) of the ceramic 11. As an alternative to using a ceramic window 11 , a polymer film may be used, the polymer film being more compliant with respect to the shape of the body and the wound 3.
Methods based on conductivity measurements Determining the water concentration in and around a wound 3 by conductivity measurements between two electrodes requires special measures because the water level in the hydrogel 6 easily dominates and conducts the electric current. The water level of the hydrogel 6 may not be of any relevance to the water conditions near the wound 3. To solve this problem conductive particles are added to a hygroscopic thin additional layer. The layer might be applied as additional thin film on top of the hydrogel shown in Fig. 7. This hygroscopic film does not respond in volume under the electrical field. However, the water content hydrogel 6 or load-uptaking material determines the degree of swelling within the ointment 5, and thus the distance between the conductive particles. As a consequence, the conductivity of the ointment 5 with the hydrogel material 6 will depend on the water concentration within. The conductive particles may be any number of small conductive materials, e.g., silver or gold nanoparticles, iron/ironoxide nanoparticles or carbonanotubes. In a preferred embodiment, the conductive particles are covalently coupled to the hygroscopic polymer matrix.
Instead of covering the whole responsive hydrogel film with a coating, a coating may be applied locally. Hygroscopic polymers may be applied between some of the electrodes 2 to provide a number of sensing compartments next to delivering compartments. Controlling and applying local coatings would allow the device to follow the wound perimeter and control wound healing while the wound is getting smaller. This may lead to better and faster wound healing as well as to decreased scar formation.
Methods based on thermal heat capacity.
Alternatively, the electrical release substrate, e.g., liquid- loaded hydrogels, could be provided with a miniature Joule heater, or an array of such heaters, and a resistive wire(s) for determining the actual temperature T. With such a set-up, the skin temperature T could be measured, and a sharp pulse in temperature with respect to skin temperature T may be created by applying current to the heater. By measuring either the rate of temperature rise or the rate of cooling down, the heat capacity, and therefore the volume of the water in the gel, may be closely estimated. It is necessary that the rise in T is rapid to avoid the body mass acting as a thermal sink.
The temperature sensors could also be used for determining if an infection is present. Normal skin temperature is 32°C and this can increase to 37°C upon infection. Provided that no infection is detected then the moisture could be maximised.
The invention is concentrating on accelerated wound healing. However, other applications are envisioned, such as beauty treatments with other stimulating agents and/or fragrances. Also electrical stimulation has been reported to be helpful in accelerating the healing process and nerve regeneration after injury. Electrical currents/charges could change cell membrane permeability, stimulate cell activities such as DNA synthesis and cell proliferation. Local electrical currents may improve arterial blood flow and reduce tissue edema and microvascular permeability. This improvement in circulation may increase tissue oxygenation. Electrical stimulation for clinical use can be delivered via various mechanisms, including direct injection of an electrical charge using metal electrodes in resistive contact with tissues, induction of eddy currents in tissues by rapidly changing magnetic fields applied externally, and creation of electrostatic field in tissues by high- voltage external capacitive plates. Among these approaches, externally applied magnetic field and capacitive plate stimulation normally activate a large area of tissue, while the metal electrodes can precisely target a small area in tissue. These effects as well as electrical-stimulated wound healing and moisture control may be presented in a single device.
While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive; the invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. In the claims, the word "comprising" does not exclude
other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. A single processor or other unit may fulfill the functions of several items recited in the claims. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measured cannot be used to advantage. Any reference signs in the claims should not be construed as limiting the scope.
Claims
1. Device for treatment of a skin wound (3) comprising: a flexible substrate adapted for attaching to the skin wound and the surrounding skin; a matrix (1) of electrodes (2); means for determining the presence of the wound (3) and/or its perimeter and/or for electrically monitoring the water content and controlling a liquid load between the matrix (1) and the wound; and means for applying a voltage between the wound and the surrounding skin.
2. Device as claimed in claim 1, wherein the means for determining the presence of the wound (3) comprise one or more sensors for detecting the real-time state of the wound (3).
3. Device according to claim 1 or 2, wherein the means for applying a voltage is adapted to control the matrix (1) of electrodes in such a way that the electrodes (2b) at and/or close to the wound (3) are charged opposite with respect to the electrodes (2a) surrounding the wound (3) or its perimeter at a predetermined distance.
4. Device according to claim 1 or 2, wherein the means for applying a voltage is adapted to control the matrix (1) of electrodes in such a way that the electric potential gradually increases or decreases from the electrodes (2b) at and/or close to the wound (3) towards the electrodes (2a) surrounding the wound or its perimeter at a predetermined distance.
5. Device according to claim 1, wherein the means for controlling a liquid load between the matrix (1) and wound includes a plurality of load-uptaking materials.
6. Device according to claim 5, wherein the plurality of load-uptaking materials includes a plurality of miniaturized liquid-containing elements.
7. Device according to claim 6, wherein the plurality of miniaturized liquid- containing elements includes a hydrogel material.
8. Device according to claim 7, wherein the hydrogel material is adapted to absorb a liquid load.
9. Device according to claim 7, wherein the hydrogel material is adapted to release the liquid load in response to an electrical stimulation from the matrix (1) of electrodes (2).
10. Device according to claim 5, wherein the plurality of load-uptaking materials is arranged within an ointment.
11. Device according to claim 5, wherein a plurality of different liquid loads are in the plurality of separate load-uptaking materials.
12. Method for electrical treatment of a skin wound comprising the following steps: - placing a matrix of electrodes attached to a flexible substrate on top of the skin wound and the surrounding skin; determining the presence of the wound and/or its perimeter and/or electrically monitoring the water content and controlling a liquid load between the matrix of electrodes and the wound; and - applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance.
13. Method according to claim 12, wherein steps of: determining the presence of the wound and/or its perimeter and/or controlling a liquid load between the matrix of electrodes and the wound; and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance are repeated in predetermined time intervals.
14. Method according to claim 12, wherein the step of electrically monitoring the water content between the matrix of electrodes and the wound includes measuring an electrical property between each electrode of the matrix and its neighboring electrodes.
15. Method according to claim 14, wherein the electrical property is selected from the group consisting of impedance, conductance and capacitance.
16. Method according to claim 12, wherein the steps of controlling a liquid load between the matrix of electrodes and the wound, and applying a different potential to the electrodes at and/or close to the wound and to the electrodes surrounding the wound at a distance results in the release of the liquid load from a plurality of load-uptaking materials between the matrix of electrodes and the wound.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08156922.0 | 2008-05-26 | ||
EP08156922A EP2127694A1 (en) | 2008-05-26 | 2008-05-26 | Multi-electrode path for monitoring and electrical stimulation of wound healing |
EP08162399.3 | 2008-08-14 | ||
EP08162399 | 2008-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009144615A1 true WO2009144615A1 (en) | 2009-12-03 |
Family
ID=40934933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/052063 WO2009144615A1 (en) | 2008-05-26 | 2009-05-18 | Moisture control within a multi-electrode patch for monitoring and electrical stimulation of wound healing |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009144615A1 (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2454990A2 (en) | 2010-11-17 | 2012-05-23 | Harald Pötzschke | Wound monitoring with textile systems for transforming measuring parameters |
DE102010054109A1 (en) | 2010-12-10 | 2012-06-14 | Ses-Entwicklung Gmbh | Method of monitoring wound, involves observing characteristics of wound and surrounding region of wound, and recording characteristics of wound as electrical signals using variable transducer system provided in wound dressing |
WO2013026999A1 (en) * | 2011-08-19 | 2013-02-28 | Pulse Innovate Ltd | A wound management system |
CN103417212A (en) * | 2012-05-21 | 2013-12-04 | 中华大学 | Biological probe assembly |
WO2014188070A1 (en) * | 2013-05-23 | 2014-11-27 | Åbo Akademi University | An arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing |
EP3179902A4 (en) * | 2014-08-11 | 2018-04-11 | The Board of Trustees of the University of Illionis | Epidermal devices for analysis of temperature and thermal transport characteristics |
EP3233181A4 (en) * | 2014-12-17 | 2018-07-25 | Morton M. Mower | Method and apparatus for improved wound healing |
WO2018144941A1 (en) | 2017-02-03 | 2018-08-09 | Bruin Biometrics, Llc | Measurement of tissue viability |
CN108992046A (en) * | 2018-07-03 | 2018-12-14 | 西北工业大学 | A kind of separate type surface of a wound monitoring system based on medical dressing |
US10206604B2 (en) | 2013-05-23 | 2019-02-19 | Cutosense Oy | Arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing |
KR20190084956A (en) * | 2017-02-03 | 2019-07-17 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of susceptibility to diabetic foot ulcers |
US10401241B2 (en) | 2016-06-08 | 2019-09-03 | The University Of British Columbia | Surface sensor arrays using ionically conducting material |
US10670429B2 (en) | 2017-02-09 | 2020-06-02 | The University Of British Columbia | Capacitive bending sensors |
US10736551B2 (en) | 2014-08-11 | 2020-08-11 | The Board Of Trustees Of The University Of Illinois | Epidermal photonic systems and methods |
US10736769B2 (en) | 2013-07-18 | 2020-08-11 | Coloplast A/S | Touch mapping |
US10831319B2 (en) | 2017-02-09 | 2020-11-10 | The University Of British Columbia | Cluster sensor |
US10898129B2 (en) | 2017-11-16 | 2021-01-26 | Bruin Biometrics, Llc | Strategic treatment of pressure ulcer using sub-epidermal moisture values |
US10950960B2 (en) | 2018-10-11 | 2021-03-16 | Bruin Biometrics, Llc | Device with disposable element |
CN112843465A (en) * | 2020-12-31 | 2021-05-28 | 北京理工大学 | Portable electric healing plaster and preparation method thereof |
US11064946B2 (en) | 2014-08-11 | 2021-07-20 | The Board Of Trustees Of The University Of Illinois | Devices and related methods for epidermal characterization of biofluids |
IT202000011881A1 (en) | 2020-05-21 | 2021-11-21 | Skin Plastic Lab S R L | COMPARISON SYSTEM OF THE PHYSIOLOGICAL PARAMETERS OF A PATIENT |
US11253192B2 (en) | 2010-05-08 | 2022-02-22 | Bruain Biometrics, LLC | SEM scanner sensing apparatus, system and methodology for early detection of ulcers |
US20220087871A1 (en) * | 2019-02-01 | 2022-03-24 | Kci Licensing, Inc. | Abdominal Negative Pressure Therapy Dressing With Remote Wound Sensing Capability |
US11284810B2 (en) | 2015-04-24 | 2022-03-29 | Bruin Biometrics, Llc | Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements |
US11337651B2 (en) | 2017-02-03 | 2022-05-24 | Bruin Biometrics, Llc | Measurement of edema |
US11471094B2 (en) | 2018-02-09 | 2022-10-18 | Bruin Biometrics, Llc | Detection of tissue damage |
CN115531591A (en) * | 2022-08-26 | 2022-12-30 | 东华大学 | Intelligent electric heating dressing for temperature-controlled segmented drug delivery and preparation method thereof |
US11642075B2 (en) | 2021-02-03 | 2023-05-09 | Bruin Biometrics, Llc | Methods of treating deep and early-stage pressure induced tissue damage |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5156591A (en) * | 1990-12-13 | 1992-10-20 | S. I. Scientific Innovations Ltd. | Skin electrode construction and transdermal drug delivery device utilizing same |
WO2005023361A2 (en) * | 2003-09-10 | 2005-03-17 | Power Paper Ltd. | Disposable electric bandage |
US20080103550A1 (en) * | 2006-10-30 | 2008-05-01 | Stuart Wenzel | Multiple electrode wound healing patch |
-
2009
- 2009-05-18 WO PCT/IB2009/052063 patent/WO2009144615A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5156591A (en) * | 1990-12-13 | 1992-10-20 | S. I. Scientific Innovations Ltd. | Skin electrode construction and transdermal drug delivery device utilizing same |
WO2005023361A2 (en) * | 2003-09-10 | 2005-03-17 | Power Paper Ltd. | Disposable electric bandage |
US20080103550A1 (en) * | 2006-10-30 | 2008-05-01 | Stuart Wenzel | Multiple electrode wound healing patch |
Non-Patent Citations (1)
Title |
---|
IGOR Y. GALAEV, BO MATTIASSON: "Smart polymers and what they could do in biotechnology and medicine", TRENDS IN BIOTECHNOLOGY, vol. 17, no. 8, 1 August 1999 (1999-08-01), pages 335 - 340, XP002541658, ISSN: 0167-7799, DOI: 10.1016/S0167-7799(99)01345-1 * |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11779265B2 (en) | 2010-05-08 | 2023-10-10 | Bruin Biometrics, Llc | SEM scanner sensing apparatus, system and methodology for early detection of ulcers |
US11253192B2 (en) | 2010-05-08 | 2022-02-22 | Bruain Biometrics, LLC | SEM scanner sensing apparatus, system and methodology for early detection of ulcers |
DE102010051459A1 (en) | 2010-11-17 | 2012-05-24 | Harald Pötzschke | Wound monitoring with textile transducer systems |
EP2454990A2 (en) | 2010-11-17 | 2012-05-23 | Harald Pötzschke | Wound monitoring with textile systems for transforming measuring parameters |
DE102010054109A1 (en) | 2010-12-10 | 2012-06-14 | Ses-Entwicklung Gmbh | Method of monitoring wound, involves observing characteristics of wound and surrounding region of wound, and recording characteristics of wound as electrical signals using variable transducer system provided in wound dressing |
WO2013026999A1 (en) * | 2011-08-19 | 2013-02-28 | Pulse Innovate Ltd | A wound management system |
CN103417212A (en) * | 2012-05-21 | 2013-12-04 | 中华大学 | Biological probe assembly |
WO2014188070A1 (en) * | 2013-05-23 | 2014-11-27 | Åbo Akademi University | An arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing |
US10166387B2 (en) | 2013-05-23 | 2019-01-01 | Cutosense Oy | Arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing |
US10206604B2 (en) | 2013-05-23 | 2019-02-19 | Cutosense Oy | Arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing |
US10736769B2 (en) | 2013-07-18 | 2020-08-11 | Coloplast A/S | Touch mapping |
US11931286B2 (en) | 2013-07-18 | 2024-03-19 | Coloplast A/S | Method of monitoring pressure applied to adhere an ostomy appliance to skin |
US11064946B2 (en) | 2014-08-11 | 2021-07-20 | The Board Of Trustees Of The University Of Illinois | Devices and related methods for epidermal characterization of biofluids |
US10736551B2 (en) | 2014-08-11 | 2020-08-11 | The Board Of Trustees Of The University Of Illinois | Epidermal photonic systems and methods |
EP3179902A4 (en) * | 2014-08-11 | 2018-04-11 | The Board of Trustees of the University of Illionis | Epidermal devices for analysis of temperature and thermal transport characteristics |
US11160458B2 (en) | 2014-08-11 | 2021-11-02 | The Board Of Trustees Of The University Of Illinois | Epidermal devices for analysis of temperature and thermal transport characteristics |
US10238860B2 (en) | 2014-12-17 | 2019-03-26 | Morton M. Mower | Method and apparatus for improved wound healing |
EP3233181A4 (en) * | 2014-12-17 | 2018-07-25 | Morton M. Mower | Method and apparatus for improved wound healing |
AU2015362725B2 (en) * | 2014-12-17 | 2020-04-16 | Morton M. Mower | Method and apparatus for improved wound healing |
US11534077B2 (en) | 2015-04-24 | 2022-12-27 | Bruin Biometrics, Llc | Apparatus and methods for determining damaged tissue using sub epidermal moisture measurements |
US11284810B2 (en) | 2015-04-24 | 2022-03-29 | Bruin Biometrics, Llc | Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements |
US11832929B2 (en) | 2015-04-24 | 2023-12-05 | Bruin Biometrics, Llc | Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements |
US10401241B2 (en) | 2016-06-08 | 2019-09-03 | The University Of British Columbia | Surface sensor arrays using ionically conducting material |
KR102492905B1 (en) * | 2017-02-03 | 2023-01-31 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of Tissue Viability |
JP2020513865A (en) * | 2017-02-03 | 2020-05-21 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニーBruin Biometrics, Llc | Tissue viability measurement |
AU2021200183C1 (en) * | 2017-02-03 | 2023-10-26 | Bbi Medical Innovations, Llc | Measurement of tissue viability |
KR20190084956A (en) * | 2017-02-03 | 2019-07-17 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of susceptibility to diabetic foot ulcers |
US10959664B2 (en) | 2017-02-03 | 2021-03-30 | Bbi Medical Innovations, Llc | Measurement of susceptibility to diabetic foot ulcers |
EP4241670A3 (en) * | 2017-02-03 | 2023-12-27 | BBI Medical Innovations, LLC | Measurement of tissue viability |
AU2018217185B2 (en) * | 2017-02-03 | 2020-10-15 | Bbi Medical Innovations, Llc | Measurement of tissue viability |
KR102283395B1 (en) * | 2017-02-03 | 2021-07-30 | 브루인 바이오메트릭스, 엘엘씨 | Determination of susceptibility to diabetic foot ulcers |
GB2591708A (en) * | 2017-02-03 | 2021-08-04 | Bruin Biometrics Llc | Measurement of susceptibility to diabetic foot ulcers |
GB2591707A (en) * | 2017-02-03 | 2021-08-04 | Bruin Biometrics Llc | Measurement of susceptibility to diabetic foot ulcers |
EP3515296A4 (en) * | 2017-02-03 | 2020-07-22 | Bruin Biometrics, LLC | Measurement of tissue viability |
GB2591708B (en) * | 2017-02-03 | 2021-11-17 | Bruin Biometrics Llc | Measurement of susceptibility to diabetic foot ulcers |
GB2591707B (en) * | 2017-02-03 | 2021-11-17 | Bruin Biometrics Llc | Measurement of susceptibility to diabetic foot ulcers |
WO2018144941A1 (en) | 2017-02-03 | 2018-08-09 | Bruin Biometrics, Llc | Measurement of tissue viability |
EP4295761A3 (en) * | 2017-02-03 | 2024-05-08 | BBI Medical Innovations, LLC | Measurement of tissue viability |
AU2021200183B2 (en) * | 2017-02-03 | 2023-06-15 | Bbi Medical Innovations, Llc | Measurement of tissue viability |
KR20220000957A (en) * | 2017-02-03 | 2022-01-04 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of Tissue Viability |
KR102346425B1 (en) * | 2017-02-03 | 2022-01-05 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of tissue viability |
JP7015305B2 (en) | 2017-02-03 | 2022-02-02 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー | Measurement of tissue viability |
KR102657975B1 (en) * | 2017-02-03 | 2024-04-17 | 비비아이 메디컬 이노베이션스, 엘엘씨 | Measurement of Tissue Viability |
US11627910B2 (en) | 2017-02-03 | 2023-04-18 | Bbi Medical Innovations, Llc | Measurement of susceptibility to diabetic foot ulcers |
KR20230021149A (en) * | 2017-02-03 | 2023-02-13 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of Tissue Viability |
JP2022058694A (en) * | 2017-02-03 | 2022-04-12 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー | Measurement of tissue viability |
US11304652B2 (en) | 2017-02-03 | 2022-04-19 | Bbi Medical Innovations, Llc | Measurement of tissue viability |
US11337651B2 (en) | 2017-02-03 | 2022-05-24 | Bruin Biometrics, Llc | Measurement of edema |
KR20190109386A (en) * | 2017-02-03 | 2019-09-25 | 브루인 바이오메트릭스, 엘엘씨 | Measurement of Tissue Survival |
JP7105767B2 (en) | 2017-02-03 | 2022-07-25 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー | Measurement of susceptibility to diabetic foot ulcers |
JP7470266B2 (en) | 2017-02-03 | 2024-04-18 | ビービーアイ、メディカル、イノベーションズ、リミテッド、ライアビリティー、カンパニー | Measurement of tissue viability |
JP2022141767A (en) * | 2017-02-03 | 2022-09-29 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー | Measurement of susceptibility to diabetic foot ulcers |
JP2020513254A (en) * | 2017-02-03 | 2020-05-14 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニーBruin Biometrics, Llc | Measuring Susceptibility to Diabetic Foot Ulcers |
US10670429B2 (en) | 2017-02-09 | 2020-06-02 | The University Of British Columbia | Capacitive bending sensors |
US10831319B2 (en) | 2017-02-09 | 2020-11-10 | The University Of British Columbia | Cluster sensor |
US11426118B2 (en) | 2017-11-16 | 2022-08-30 | Bruin Biometrics, Llc | Strategic treatment of pressure ulcer using sub-epidermal moisture values |
US10898129B2 (en) | 2017-11-16 | 2021-01-26 | Bruin Biometrics, Llc | Strategic treatment of pressure ulcer using sub-epidermal moisture values |
US11191477B2 (en) | 2017-11-16 | 2021-12-07 | Bruin Biometrics, Llc | Strategic treatment of pressure ulcer using sub-epidermal moisture values |
US11980475B2 (en) | 2018-02-09 | 2024-05-14 | Bruin Biometrics, Llc | Detection of tissue damage |
US11471094B2 (en) | 2018-02-09 | 2022-10-18 | Bruin Biometrics, Llc | Detection of tissue damage |
CN108992046A (en) * | 2018-07-03 | 2018-12-14 | 西北工业大学 | A kind of separate type surface of a wound monitoring system based on medical dressing |
US11600939B2 (en) | 2018-10-11 | 2023-03-07 | Bruin Biometrics, Llc | Device with disposable element |
US10950960B2 (en) | 2018-10-11 | 2021-03-16 | Bruin Biometrics, Llc | Device with disposable element |
US11342696B2 (en) | 2018-10-11 | 2022-05-24 | Bruin Biometrics, Llc | Device with disposable element |
US11824291B2 (en) | 2018-10-11 | 2023-11-21 | Bruin Biometrics, Llc | Device with disposable element |
US20220087871A1 (en) * | 2019-02-01 | 2022-03-24 | Kci Licensing, Inc. | Abdominal Negative Pressure Therapy Dressing With Remote Wound Sensing Capability |
IT202000011881A1 (en) | 2020-05-21 | 2021-11-21 | Skin Plastic Lab S R L | COMPARISON SYSTEM OF THE PHYSIOLOGICAL PARAMETERS OF A PATIENT |
WO2021234484A1 (en) | 2020-05-21 | 2021-11-25 | Skin Plastic Lab S.R.L. | System for comparing the physiological parameters of a patient |
CN112843465B (en) * | 2020-12-31 | 2023-09-19 | 北京理工大学 | Portable electric healing plaster and preparation method thereof |
CN112843465A (en) * | 2020-12-31 | 2021-05-28 | 北京理工大学 | Portable electric healing plaster and preparation method thereof |
US11642075B2 (en) | 2021-02-03 | 2023-05-09 | Bruin Biometrics, Llc | Methods of treating deep and early-stage pressure induced tissue damage |
US12097041B2 (en) | 2021-02-03 | 2024-09-24 | Bruin Biometrics, Llc | Methods of treating deep and early-stage pressure induced tissue damage |
CN115531591B (en) * | 2022-08-26 | 2023-06-27 | 东华大学 | Intelligent electrothermal dressing with temperature control and sectional drug delivery functions and preparation method thereof |
CN115531591A (en) * | 2022-08-26 | 2022-12-30 | 东华大学 | Intelligent electric heating dressing for temperature-controlled segmented drug delivery and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009144615A1 (en) | Moisture control within a multi-electrode patch for monitoring and electrical stimulation of wound healing | |
Freedman et al. | Breakthrough treatments for accelerated wound healing | |
Lu et al. | In-situ doping of a conductive hydrogel with low protein absorption and bacterial adhesion for electrical stimulation of chronic wounds | |
AU2002314879B2 (en) | Apparatus and methods for facilitating wound healing | |
JP5826930B2 (en) | System and method for healing wounds | |
Ousey et al. | The importance of hydration in wound healing: reinvigorating the clinical perspective | |
Park et al. | Electrical stimulation modulates the expression of multiple wound healing genes in primary human dermal fibroblasts | |
AU2002314879A1 (en) | Apparatus and methods for facilitating wound healing | |
US20030130707A1 (en) | Non-invasive capacitively coupled electrical stimulation device for treatment of soft tissue wounds | |
JP2007504882A5 (en) | ||
EP2127694A1 (en) | Multi-electrode path for monitoring and electrical stimulation of wound healing | |
CN204637074U (en) | A kind of pain relieving speed more wound dressing | |
Li et al. | Toward controlled electrical stimulation for wound healing based on a precision layered skin model | |
Gnanasambanthan et al. | Development of a flexible and wearable microelectrode array patch using a screen-printed masking technique for accelerated wound healing | |
Nazari-Vanani et al. | Flexible Triboelectric Nanogenerator for Promoting the Proliferation and Migration of Human Fibroblast Cells | |
Gomez et al. | Clinical applications and benefits of using closed-incision negative pressure therapy for incision and surrounding soft tissue management: a novel approach for comorbid wounds | |
Gefen | The influence zone: a critical performance measure for negative pressure wound therapy systems | |
Kushwaha et al. | Nanomaterial-Based Therapy for Wound Healing. Nanomaterials 2022, 12, 618 | |
US9889236B2 (en) | Scalable microfluidic based artificial skin | |
WO2023024330A1 (en) | Wound healing patch composition and preparation method therefor and application thereof | |
US20220193403A1 (en) | System and method for wound healing | |
Sheen et al. | Efficacy of negative pressure wound therapy in early diabetic foot ulcer management in comparison with advanced moist wound therapy | |
EP3104815B1 (en) | Bioresonant dressing for rapid healing of wounds, process for obtaining the same and use thereof | |
Liu et al. | Effect of Electrospun Nanofibers on Diabetic Wound Healing and Epidermal Growth Factor | |
Preetam et al. | Electrical stimulation: a novel therapeutic strategy to heal biological wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09754242 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09754242 Country of ref document: EP Kind code of ref document: A1 |